Document:

Fifth Supplemental Indenture

 Exhibit 4.1 
 EXECUTION VERSION 
 COVIDIEN INTERNATIONAL FINANCE S.A., 
 as Issuer, 
 COVIDIEN LTD., 
 as Guarantor, 
 COVIDIEN plc, 
 as Guarantor, 
 AND 
 DEUTSCHE BANK TRUST COMPANY AMERICAS, 
 as
Trustee 
 FIFTH SUPPLEMENTAL INDENTURE 
 Dated as of June 4, 2009 

 THIS FIFTH SUPPLEMENTAL INDENTURE is dated as of June 4, 2009 among Covidien International Finance
S.A., a Luxembourg company (the “Company”), Covidien Ltd., a Bermuda company (“Covidien Ltd.”), Covidien plc, an Irish company (“Covidien plc”), and Deutsche Bank Trust Company Americas, a New York
banking corporation (the “Trustee”). 
 RECITALS 
 A. The Company, Covidien Ltd. and the Trustee executed and delivered an Indenture (the “Base Indenture”), as supplemented by the First
through Fourth Supplemental Indentures (the “Prior Supplemental Indentures” and, together with the Base Indenture, the “Indenture”), each dated as of October 22, 2007. 
 B. Covidien Ltd. and Covidien plc are engaging in a transaction pursuant to which Covidien Ltd. will become a wholly-owned subsidiary of Covidien plc,
and Covidien plc will become the successor company for purposes of public filings with the Securities and Exchange Commission. 
 C. The
Boards of Directors of the Company and Covidien Ltd. have determined it is desirable to add Covidien plc as an additional guarantor under the Indenture with respect to the Securities outstanding as of the date hereof and Securities that may be
issued from time to time after the date hereof under the Indenture, to substitute Covidien plc for Covidien Ltd. with respect to certain provisions of the Indenture and to make certain other amendments to the Indenture. 
 D. Pursuant to this Fifth Supplemental Indenture, Covidien plc is willing to become, jointly and severally with Covidien Ltd., a guarantor under the
Indenture and to observe all of the covenants and agreements of the Indenture to be performed or observed by Covidien Ltd. 
 E. This Fifth
Supplemental Indenture is being entered into pursuant to Section 9.01(h) of the Indenture and the entry into this Fifth Supplemental Indenture by the parties hereto is in all respects authorized by the provisions of the Indenture. 

F. All things necessary to make this Fifth Supplemental Indenture a valid indenture and agreement according to its terms have been done. 

NOW, THEREFORE, for and in consideration of the foregoing premises, the Company, Covdien Ltd., Covidien plc and the Trustee mutually covenant and
agree for the equal and proportionate benefit of the respective holders from time to time of the Securities as follows: 
 ARTICLE I 

 Section 1.1 Amendments to Base Indenture. 
 (1) Article I of the Base Indenture is amended as follows: 
 (A) The following new definition is added in
appropriate alphabetical order: 
  

 1 

 “Holdco” means Covidien plc until a successor entity shall have become
such pursuant to Article X, and thereafter “Holdco” shall mean such successor entity. 
 (B) The following definitions are amended
to read as follows: 
 “Board of Directors” means the Board of Directors of the Company, Parent or Holdco, as
applicable, or any duly authorized committee of such Board of Directors. 
 “Board Resolution” means a copy
of a resolution certified by the Secretary or an Assistant Secretary of the Company, Parent or Holdco to have been duly adopted by its Board of Directors and to be in full force and effect on the date of such certification. 
 “Foreign Currency” means a currency, currency unit or composite currency, including the euro, issued by the government of
one or more countries other than the United States or by any recognized confederation or association of such governments or a composite currency the value of which is determined by reference to the values of the currencies of any group of countries.

 “Guarantee” means the unconditional and unsubordinated guarantee, jointly and severally, by Parent and
Holdco of the due and punctual payment of principal of and interest on a series of Securities when and as the same shall become due and payable, whether at the stated maturity, by acceleration, call for redemption or otherwise in accordance with the
terms of the Securities and this Indenture. 
 “Officer” means any managing director, the chairman or any
vice chairman of the Board of Directors, the chief executive officer, the president, the chief financial officer, any vice president, the treasurer, any assistant treasurer, the secretary or any assistant secretary of the Company, Parent or Holdco,
as the case may be. 
 “Officer’s Certificate” means a certificate, signed by any managing director or
by the chairman or any vice chairman of the Board of Directors, or the chief executive officer, president, chief financial officer or vice president or the secretary or any assistant secretary or the treasurer or any assistant treasurer of the
Company, Parent or Holdco, as the case may be, that is delivered to the Trustee in accordance with the terms hereof. Each such certificate shall include the statements provided for in Section 13.06, if and to the extent required by the
provisions thereof. 
 “Opinion of Counsel” means an opinion in writing of legal counsel, who may be an
Officer or employee of or counsel for Holdco, Parent or the Company that is delivered to the Trustee in accordance with the terms hereof. Each such opinion shall include the statements provided for in Section 13.06, if and to the extent
required by the provisions thereof. 
 (2) Article II of the Base Indenture is amended as follows: 
 (A) Sections 2.04, 2.05, 2.06, 2.07 and 2.11 are amended by inserting the words “and Holdco” immediately following each use of the word
“Parent”, except that the third paragraph of 

  

 2 

 
Section 2.05(a) is amended to delete and replace the words “Company and Parent” with the words “Company, Parent and Holdco”.

 (B) The form of the Guarantee set forth in Section 2.16 is amended to read as follows 
 GUARANTEE 
 For value
received, each of Covidien plc and Covidien Ltd. hereby jointly and severally, absolutely, unconditionally and irrevocably guarantees to the holder of this Security the payment of principal of, premium, if any, and interest on, the Security upon
which this Guarantee is set forth in the amounts and at the time when due and payable whether by declaration thereof, or otherwise, and interest on the overdue principal and interest, if any, of such Security, if lawful, to the holder of such
Security and the Trustee on behalf of the Holders, all in accordance with and subject to the terms and limitations of such Security and Article XV of the Indenture. This Guarantee will not become effective until the Trustee or Authenticating Agent
duly executes the certificate of authentication on this Security. This Guarantee shall be governed by and construed in accordance with the laws of the State of New York, without regard to conflict of law principles thereof. 
 Dated: 
  

			
	COVIDIEN LTD.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	PRESENT when the COMMON SEAL of COVIDIEN PLC was affixed hereto
	
	  

	Director
	
	  

	Secretary

 (3) Article III of the Base Indenture is amended as follows: 
 Section 3.03(b) is amended to insert the words “and Holdco” immediately following each use of the word “Parent”. 
 (4) Article IV of the Base Indenture is amended as follows: 
 (A) Section 4.03 is amended to insert the word “Holdco,” immediately preceding each use of the word “Parent”. 
  

 3 

 (B) Section 4.04 is be amended to read as follows: 
 Section 4.04 Statement by Officers as to Default. 
 So long as any of the Securities remain outstanding, the Company, Parent and Holdco will furnish to the Trustee on or before March 31
in each year a brief certificate (which need not comply with Section 13.06) executed by the principal executive, financial or accounting officer of each of the Company, Parent and Holdco on their respective behalf as to his or her knowledge of
the Company’s, Parent’s or Holdco’s, as the case may be, compliance with all covenants and agreements under this Indenture required to be complied with by the Company, Parent and Holdco, respectively (such compliance to be determined
without regard to any period of grace or requirement of notice provided under this Indenture). Such certificate need not include a reference to any non-compliance that has been fully cured prior to the date as of which such certificate speaks.

 The Company shall provide written notice to the Trustee within 30 days of the occurrence of any Event of Default under
Section 6.01. 
 (5) Article V of the Base Indenture is amended as follows: 
 Section 5.03 is amended to delete and replace each use of the word “Parent” with the word “Holdco”. 
 (6) Article VI of the Base Indenture is amended as follows: 
 (A) Clauses (4) and (5) of Section 6.01(a), the second paragraph of Section 6.01(a), Section 6.01(b) and (c) and Section 6.08 are amended to insert the word “Holdco,”
immediately preceding each use of the word “Parent”. 
 (B) The second paragraph of Section 6.01(a) is amended to insert the
word “Holdco’s,” immediately preceding the word “Parent’s”. 
 (C) Clauses (6) and (7) of
Section 6.01(a) and Section 6.02 are amended to delete and replace each use of the words “Company or Parent” with the words “Company, Parent or Holdco”. 
 (7) Article VII of the Base Indenture is amended as follows: 
 Section 7.06(a) is amended to delete and replace the words “Company and Parent” with the words “Company, Parent and Holdco”. 
 (8) Article VIII of the Base Indenture is amended as follows: 
 Section 8.04 is amended to insert the word “Holdco,” immediately preceding each use of the word “Parent”. 
 (9) Article IX of the Base Indenture is amended as follows: 
  

 4 

 (A) Sections 9.01, 9.02, 9.03 and 9.05 are amended to insert” with the word “Holdco,”
immediately preceding each use of the word “Parent”, other than the use of the word “Parent” in Section 9.01(i). 
 (B) Section 9.01(i) is amended to insert the words “Holdco or” immediately preceding the word “Parent”. 
 (10) Article X of the Base Indenture is amended as follows: 
 Sections 10.01 and 10.02 are amended to insert the word
“Holdco,” immediately preceding each use of the word “Parent”. 
 (11) Article XI of the Base Indenture is amended as
follows: 
 Sections 11.02 through 11.07 are amended to insert the word “Holdco,” immediately preceding each use of the word
“Parent” and Sections 11.02 and 11.03 are amended to insert the word “Holdco’s,” immediately preceding each use of the word “Parent’s”. 
 (12) Article XII of the Base Indenture is amended as follows: 
 Section 12.01 is amended to insert the word “Holdco,” immediately preceding each use of the word “Parent”. 
 (13) Article XIII of the Base Indenture is amended as follows: 
 (A) Sections 13.01, 13.02, 13.03, 13.06 and
13.13 are amended to insert the word “Holdco,” immediately preceding each use of the word “Parent”, other than the second use of the word “Parent” in Section 13.03. 
 (B) Pursuant to Section 13.03 of the Base Indenture, the Company hereby designates the following as an additional address for subsequent notices or
communications to Parent and Section 13.03 is amended to insert such additional address immediately following the address for notices sent to Parent: 
  

			
	If to Holdco:	  	        Covidien plc
		  	        Cherrywood Business Park
		  	        Block G, First Floor
		  	        Loughlinstown Co Dublin
		  	        Ireland
		  	        Phone: 353 1 4393000
		
		  	        Attention: John W. Kapples, Secretary

 (14) Article XIV of the Base Indenture is amended as follows: 
 (A) Sections 14.01 and 14.02 are amended to delete and replace each use of the words “the Company or Parent” and “Parent or the
Company” with the words “Holdco, Parent or the 

  

 5 

 
Company”, other than in the last sentence of Section 14.01, and Section 14.02 is amended further to insert the word
“Holding’s,” before the word “Parent’s”. 
 (B) The last sentence of Section 14.01 is amended to read as
follows: 
 Prior to the giving of any notice of redemption described in this paragraph, the Company shall deliver to the
Trustee (i)(A) certificate signed by two directors of the Company stating that the obligation to pay Additional Amounts cannot be avoided by the Company taking commercially reasonable measures available to it, (B) a certificate signed by
two Officers of Parent stating that the obligation to pay Additional Amounts cannot be avoided by Parent taking commercially reasonable measures available to it or (C) a certificate signed by two Officers of Holdco stating that the obligation
to pay Additional Amounts cannot be avoided by Holdco taking commercially reasonable measures available to it, as the case may be, and (ii) a written opinion of independent legal counsel to Holdco, Parent or the Company, as the case may be, of
recognized standing to the effect that the Company has or there is a material probability that it will become obligated to pay Additional Amounts as a result of a change, amendment, official interpretation or application described above and that
Holdco, Parent or the Company, as the case may be, cannot avoid the payment of such Additional Amounts by taking commercially reasonable measures available to it. 
 (15) Article XV of the Base Indenture is amended to read as follows: 
 ARTICLE XV 
 GUARANTEES 
 Section 15.01
Guarantee. 
 Each of Holdco and Parent hereby jointly and severally, fully and unconditionally guarantees (i) to
each holder of each Security that is authenticated and delivered by the Trustee, and (ii) to the Trustee on behalf of such Holder, the due and punctual payment of the principal of, premium, if any, and interest on such Security when and as the
same shall become due and payable, whether at the stated maturity, by acceleration, call for redemption or otherwise, in accordance with the terms of such Security and of this Indenture. In case of the failure of the Company punctually to make any
such payment, each of Holdco and Parent hereby agrees to cause such payment to be made punctually when and as the same shall become due and payable, whether at the stated maturity or by acceleration, call for redemption or otherwise, and as if such
payment were made by the Company. 
 Each of Holdco and Parent hereby agrees that its obligations hereunder shall be absolute
and unconditional, irrespective of, and shall be unaffected by, the validity, regularity or enforceability of such Security or this Indenture, the absence of any action to enforce the same or any release, amendment, waiver or indulgence granted to
the Company, Parent or Holdco or any consent to departure from any requirement of any other guarantee of all or any of the Securities or any other circumstances which might otherwise constitute a legal or equitable discharge or defense of a surety
or guarantor. 

  

 6 

 
Each of Holdco and Parent hereby waives the benefits of diligence, presentment, demand for payment, any requirement that the Trustee or any of the Holders
protect, secure, perfect or insure any security interest in or other lien on any property subject thereto or exhaust any right or take any action against the Company or any other Person or any collateral, filing of claims with a court in the event
of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest or notice with respect to such Security or the indebtedness evidenced thereby and all demands whatsoever, and covenants that this
Guarantee will not be discharged in respect of such Security except by complete performance of the obligations contained in such Security and in such Guarantee. Each of Holdco and Parent agrees that if, after the occurrence and during the
continuance of an Event of Default, the Trustee or any of the Holders of the applicable series of Securities are prevented by applicable law from exercising their respective rights to accelerate the maturity of such Securities, to collect interest
on such Securities, or to enforce or exercise any other right or remedy with respect to such Securities, Holdco and Parent agree to pay to the Trustee for the account of such Holders, upon demand therefor, the amount that would otherwise have been
due and payable had such rights and remedies been permitted to be exercised by the Trustee or any of such Holders. 
 Each of
Holdco and Parent shall be subrogated to all rights of the holders of the Securities against the Company in respect of any amounts paid by Holdco or Parent, as the case may be, on account of such Security pursuant to the provisions of its Guarantee
or this Indenture; provided, however, that Holdco or Parent, as the case may be, shall not be entitled to enforce or to receive any payment arising out of, or based upon, such right of subrogation until the principal of and interest on all
Securities of such series issued hereunder shall have been paid in full. 
 The Guarantee shall remain in full force and
effect and continue to be effective should any petition be filed by or against the Company for liquidation or reorganization, should the Company become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be
appointed for all or any part of the Company’s assets, and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of such Securities, is, pursuant to
applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any holder of such Securities, whether as a “voidable preference,” “fraudulent transfer,” or otherwise, all as though such payment or
performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, such Securities shall, to the fullest extent permitted by law, be reinstated and deemed reduced only by such amount paid
and not so rescinded, reduced, restored or returned. 
 Any term or provision of the Guarantee to the contrary
notwithstanding, the aggregate amount of the obligations guaranteed hereunder shall be reduced to the extent necessary to prevent such Guarantee from violating or becoming voidable under applicable law relating to fraudulent conveyance or fraudulent
transfer or similar laws affecting the rights of creditors generally. 
  

 7 

 Section 15.02 Execution and Delivery of Guarantee. 
 The Guarantee shall include the terms of the Guarantee set forth in Section 15.01 and shall be substantially in the form established
pursuant to Section 2.16. Each of Holdco and Parent hereby agrees to execute its Guarantee, in a form established pursuant to Section 2.16, on each Security authenticated and delivered by the Trustee. 
 The Guarantee shall be executed on behalf of Holdco and Parent, in each case, by any one of its chairman of the Board of Directors,
president, vice presidents or other person duly authorized by Holdco’s or Parent’s Board of Directors, as the case may be. The signature of any or all of these persons on the Guarantee may be manual or facsimile. 
 A Guarantee bearing the manual or facsimile signature of individuals who were at any time the proper officers of Holdco or Parent, as the
case may be, shall bind Holdco or Parent, as the case may be, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the authentication and delivery of any Security or did not hold such offices at the date of
such Guarantee. 
 The delivery of any Security by the Trustee, after the authentication thereof, shall constitute due
delivery of the Guarantee on behalf of Holdco and Parent and shall bind Holdco and Parent notwithstanding the fact that the Guarantee does not bear the signature of Holdco or Parent. Each of Holdco and Parent agrees that its Guarantee set forth in
Section 15.01 and in the form of Guarantee established pursuant to Section 2.16 shall remain in full force and effect notwithstanding any failure to execute a Guarantee on any such Security. 
 Section 15.03 Release of Guarantee. 
 Notwithstanding anything in this Article XV to the contrary, concurrently with the payment in full of the principal of, premium, if any, and interest on Securities of a series, each of Holdco and Parent shall be
released from and relieved of its obligations under this Article XV with respect to the Securities of such series. Upon the delivery by the Company to the Trustee of an Officer’s Certificate and an Opinion of Counsel to the effect that the
transaction giving rise to the release of this Guarantee was made by the Company in accordance with the provisions of this Indenture and the Securities, the Trustee shall execute any documents reasonably required in order to evidence the release of
each of Holdco and Parent from its obligations under this Guarantee. If any of the obligations to pay the principal of, premium, if any, and interest on such Securities and all other obligations of the Company are revived and reinstated after the
termination of this Guarantee, then all of the obligations of each of Holdco and Parent under this Guarantee shall be revived and reinstated as if this Guarantee had not been terminated until such time as the principal of, premium, if any, and
interest on such Securities are paid in full, and each of Holdco and Parent shall enter into an amendment to this Guarantee, reasonably satisfactory to the Trustee, evidencing such revival and reinstatement. 
 Section 1.2 Amendments to Prior Supplemental Indentures. 
  

 8 

	 	(1)	Section 1.2 of each of the Prior Supplemental Indentures is amended as follows: 

  

	 	(A)	The definition of “Change of Control” is amended to delete and replace each use of the word “Parent” with the word “Holdco”. 

 

	 	(B)	The definitions of “Consolidated Net Worth”, “Consolidated Tangible Assets” and “Indebtedness” are each amended to delete and replace each use of the
word “Parent” with the word “Holdco”. 

  

	 	(C)	The following definitions are amended to read as follows: 

 “Non-Recourse Indebtedness” means Indebtedness upon the enforcement of which recourse may be had by the holder(s) thereof only to identified assets of Holdco, Parent or the Company or any Subsidiary
of Holdco, Parent or the Company and not to Holdco, Parent or the Company or any Subsidiary of Holdco, Parent or the Company personally (subject to, for the avoidance of doubt, customary exceptions contained in non-recourse financings to the
non-recourse nature of the obligations thereunder). 
 “Principal Property” means any U.S. manufacturing,
processing or assembly plant or any U.S. warehouse or distribution facility of Holdco or any of its Subsidiaries that is used by any U.S. Subsidiary of the Company and (A) is owned by Parent or any Subsidiary of Parent on the date hereof,
(B) the initial construction of which has been completed after the date hereof, or (C) is acquired after the date hereof, in each case, other than any such plants, facilities, warehouses or portions thereof, that in the opinion of the
Board of Directors of Holdco, are not collectively of material importance to the total business conducted by Holdco and its subsidiaries as an entirety, or that has a net book value (excluding any capitalized interest expense), on the date hereof in
the case of clause (A) of this definition, on the date of completion of the initial construction in the case of clause (B) of this definition or on the date of acquisition in the case of clause (C) of this definition, of less than
2.0% of Consolidated Tangible Assets on the consolidated balance sheet of Parent and its subsidiaries as of the applicable date if the applicable date is prior to the date of the Fifth Supplemental Indenture to the Base Indenture or of Holdco and
its subsidiaries as of the applicable date if the applicable date is on or after the date of the Fifth Supplemental Indenture to the Base Indenture. 
 “Sale and Lease-Back Transaction” means an arrangement with any Person providing for the leasing by the Company or a Restricted Subsidiary of any Principal Property whereby such Principal Property has
been or is to be sold or transferred by the Company or a Restricted Subsidiary to such Person other than Holdco, Parent, the Company or any of their respective Subsidiaries; provided, however, that the foregoing shall not apply to any such
arrangement involving a lease for a term, including renewal rights, for not more than three years. 
 (2) Section 1.3 of each of the
Prior Supplemental Indentures shall be amended as follows: 
 Section 1.3(1)(e) shall be amended to read as follows: 
  

 9 

 (e) liens securing Indebtedness owing by any Restricted Subsidiary to the Company, Parent
or Holdco or a subsidiary thereof or by the Company to Parent or Holdco; 
 (3) Section 1.4 of each of the Prior Supplemental Indentures
is amended as follows: 
 The additional event established and constituting an Event of Default under Section 6.01 of the Base Indenture
is amended to read as follows: 
 (9) an event of default shall happen and be continuing with respect to the Company’s,
Parent’s or Holdco’s Indebtedness for borrowed money (other than Non-Recourse Indebtedness) under any indenture or other instrument evidencing or under which the Company, Parent or Holdco shall have a principal amount outstanding (such
amount with respect to original issue discount bonds or zero coupon notes, bonds or debentures or similar securities based on the accreted amount determined in accordance with United States generally accepted accounting principles and as of the date
of the most recently prepared consolidated balance sheet of the Company, Parent or Holdco, as the case may be) in excess of $100,000,000, and such event of default shall involve the failure to pay the principal of such Indebtedness on the final
maturity date thereof after the expiration of any applicable grace period with respect thereto, or such Indebtedness shall have been accelerated so that the same shall have become due and payable prior to the date on which the same would otherwise
have become due and payable, and such acceleration shall not be rescinded or annulled within ten Business Days after notice thereof shall have been given to the Company, Parent and Holdco by the Trustee, or to the Company, Parent, Holdco and the
Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Securities of all series affected thereby; provided that, if such event of default under such indenture or instrument shall be remedied or cured by the Company,
Parent or Holdco or waived by the requisite holders of such Indebtedness, then the Event of Default hereunder by reason thereof shall be deemed likewise to have been thereupon remedied, cured or waived without further action upon the part of either
the Trustee or any of the Securityholders, and provided further, however, that subject to the provisions of Sections 7.01 and 7.02, the Trustee shall not be charged with knowledge of any such event of default unless written notice thereof shall
have been given to the Trustee by the Company, Parent or Holdco, as the case may be, by the holder or an agent of the holder of any such Indebtedness, by the trustee then acting under any indenture or other instrument under which such default shall
have occurred, or by the Holders of not less than 25% in the aggregate principal amount of Outstanding Securities of all series affected thereby. 
 (4) The forms of Securities set forth in Exhibit A to each of the Prior Supplemental Indentures are amended to read as set forth in Annex A hereto with respect to the First Supplemental Indenture, Annex B hereto with respect to the Second
Supplemental Indenture, Annex C hereto with respect to the Third Supplemental Indenture and Annex D hereto with respect to the Fourth Supplemental Indenture. Pursuant to Section 9.04 of the Base Indenture, new Securities of each such series
shall be prepared by the Company, authenticated by the Trustee and delivered in exchange for the Securities of each such series Outstanding as of the date hereof. 
  

 10 

 ARTICLE II 
 MISCELLANEOUS 
 Section 2.1 Definitions. 
 Capitalized terms used but not defined in this Fifth Supplemental Indenture shall have the meanings ascribed thereto in the Indenture. 
 Section 2.2 Confirmation of Indenture. 
 The Indenture, as supplemented and amended by this Fifth Supplemental Indenture, is in all respects ratified and confirmed, and the Indenture, this Fifth Supplemental Indenture and all indentures supplemental thereto
shall be read, taken and construed as one and the same instrument. Holdco, by its execution of this Fifth Supplemental Indenture, agrees to be bound by the terms of the Indenture, as so supplemented, that are applicable to Holdco. 
 Section 2.3 Concerning the Trustee. 
 In carrying out the Trustee’s responsibilities hereunder, the Trustee shall have all of the rights, protections and immunities which it possesses under the Indenture. The Trustee assumes no responsibility for the
correctness of the recitals contained herein. The Trustee makes no representations as to the validity or sufficiency of this Fifth Supplemental Indenture. 
 Section 2.4 GOVERNING LAW. 
 THIS FIFTH SUPPLEMENTAL INDENTURE SHALL BE DEEMED TO BE A
CONTRACT MADE UNDER THE INTERNAL LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS OF SAID STATE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THAT WOULD REQUIRE THE APPLICATION OF ANY OTHER LAW.

 Section 2.5 Effectiveness. 
 This Fifth Supplemental Indenture shall become effective upon execution by the Company, Covidien Ltd., Covidien plc and the Trustee. 
 Section 2.6 Counterparts. 
 This Fifth Supplemental Indenture may be executed in any
number of counterparts each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. 
 Section 2.7 No Benefit. 
 Nothing in this Fifth Supplemental Indenture, express or implied, shall give to any
Person other than the parties hereto and their successors or assigns, and the holders of the Securities, any 

  

 11 

 
benefit or legal or equitable rights, remedy or claim under this Fifth Supplemental Indenture or the Indenture. 
 [Remainder of page intentionally left blank] 
  

 12 

 IN WITNESS WHEREOF, the parties hereto have caused this Fifth Supplemental Indenture to be duly executed
all as of the day and year first above written. 
  

			
	COVIDIEN INTERNATIONAL FINANCE S.A.
		
	By:	 	 /s/ Anton Stadtbaumer

	Name:	 	Anton Stadtbaumer
	Title:	 	Managing Director
	
	COVIDIEN LTD.
		
	By:	 	 /s/ Charles J. Dockendorff

	Name:	 	Charles J. Dockendorff
	Title:	 	 Executive Vice President &
 Chief Financial Officer

	
	PRESENT when the COMMON SEAL of COVIDIEN PLC was affixed hereto
	
	 /s/ Richard J. Meelia

	 Richard J. Meelia
 Director

	
	 /s/ John W. Kapples

	 John W. Kapples
 Secretary

	
	 DEUTSCHE BANK TRUST COMPANY AMERICAS,
 as Trustee

		
	By:	 	 /s/ Wanda Camacho

	Name:	 	Wanda Camacho
	Title:	 	Vice President
		
	By:	 	 /s/ Carol Ng

	Name:	 	Carol Ng
	Title:	 	Vice President

 ANNEX A 
 FORM OF 5.150% SENIOR NOTES 
 [Insert the Private Placement Legend and/or the Global Security
legend, as applicable] 
 5.150% SENIOR NOTES DUE 2010 
  

			
	 No. [    ]
	  	$[             ]
	 CUSIP No. [            ]
	  	

 COVIDIEN INTERNATIONAL FINANCE S.A. 
 promises to pay to Cede & Co. or registered assigns, the principal sum of [            ] Dollars on October 15, 2010. 
 Interest Payment Dates: April 15 and October 15 
 Record Dates:
April 1 and October 1 
 Each holder of this Security (as defined below), by accepting the same, agrees to and shall be bound by the
provisions hereof and of the Indenture described herein, and authorizes and directs the Trustee described herein on such holder’s behalf to be bound by such provisions. Each holder of this Security hereby waives all notice of the acceptance of
the provisions contained herein and in the Indenture and waives reliance by such holder upon said provisions. 
 This Security shall not be
entitled to any benefit under the Indenture, or be valid or become obligatory for any purpose, until the Certificate of Authentication hereon shall have been signed by or on behalf of the Trustee. The provisions of this Security are continued on the
reverse side hereof, and such continued provisions shall for all purposes have the same effect as though fully set forth at this place. 
 IN WITNESS
WHEREOF, the Company has caused this instrument to be signed in accordance with Section 2.04 of the Indenture. 
 Date:
[            ] 
  

	
	COVIDIEN INTERNATIONAL FINANCE S.A.
	
	  

	Name:
	Title:
	
	[If second signature is applicable:]
	
	  

	Name:

  

 A-1 

	
	Title:

  

 A-2 

 CERTIFICATE OF AUTHENTICATION 
 This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 
  

			
	DEUTSCHE BANK TRUST COMPANY
AMERICAS, as Trustee
		
	By:	 	  

		 	Authorized Signatory
		
	By:	 	  

		 	Authorized Signatory
		
	Dated:	 	[         ]

  

 A-3 

 For value received, each of Covidien plc and Covidien Ltd. hereby jointly and severally, absolutely,
unconditionally and irrevocably guarantees to the holder of this Security the payment of principal of, premium, if any, and interest on, the Security upon which this Guarantee is set forth in the amounts and at the time when due and payable whether
by declaration thereof, or otherwise, and interest on the overdue principal and interest, if any, of such Security, if lawful, to the holder of such Security and the Trustee on behalf of the Holders, all in accordance with and subject to the terms
and limitations of such Security and Article XV of the Indenture. This Guarantee will not become effective until the Trustee or Authenticating Agent duly executes the certificate of authentication on this Security. This Guarantee shall be governed
by and construed in accordance with the laws of the State of New York, without regard to conflict of law principles thereof. 
 Dated: 
  

			
	COVIDIEN LTD.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	PRESENT when the COMMON SEAL of COVIDIEN PLC was affixed hereto
	
	  

	Director
	
	  

	Secretary

  

 A-4 

 Covidien International Finance S.A. 
 5.150% Senior Notes due 2010 
 This security is one of a duly authorized series of debt
securities of Covidien International Finance S.A., a Luxembourg company (the “Company”), issued or to be issued in one or more series under and pursuant to an Indenture for the Company’s unsubordinated debt securities, dated as of
October 22, 2007 (the “Base Indenture”), duly executed and delivered by and among the Company, Covidien Ltd. (“Parent”) and Deutsche Bank Trust Company Americas (the “Trustee”), as supplemented by the First
Supplemental Indenture, dated as of October 22, 2007 (the “First Supplemental Indenture”), by and among the Company, Parent and the Trustee, and the Fifth Supplemental Indenture dated as of June 4, 2009 (the “Fifth
Supplemental Indenture”), by and among the Company, Parent, Covidien plc (“Holdco”) and the Trustee. The Base Indenture as supplemented and amended by the First Supplemental Indenture and the Fifth Supplemental Indenture is referred
to herein as the “Indenture.” By the terms of the Base Indenture, the debt securities issuable thereunder are issuable in series that may vary as to amount, date of maturity, rate of interest and in other respects as provided in the Base
Indenture. This security is one of the series designated on the face hereof (individually, a “Security,” and collectively, the “Securities”), and reference is hereby made to the Indenture for a description of the rights,
limitations of rights, obligations, duties and immunities of the Trustee, the Company, Parent, Holdco and the holders of the Securities (the “Securityholders”). Capitalized terms used herein and not otherwise defined shall have the
meanings given them in the Base Indenture or the First Supplemental Indenture, as applicable, in each case as amended by the Fifth Supplemental Indenture. 
 1. Interest. The Company promises to pay interest on the principal amount of this Security at an annual rate of 5.150%. The Company will pay interest semi-annually on April 15 and October 15 of
each year (each such day, an “Interest Payment Date”). If any Interest Payment Date, redemption date or maturity date of this Security is not a Business Day, then payment of interest or principal (and premium, if any) shall be made on the
next succeeding Business Day with the same force and effect as if made on the date such payment was due, and no interest shall accrue for the period after such date to the date of such payment on the next succeeding Business Day. Interest on the
Securities will accrue from the most recent date to which interest has been paid or duly provided for or, if no interest has been paid, from the date of issuance; provided that, if there is no existing Default in the payment of interest, and if this
Security is authenticated between a regular record date referred to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date; and provided, further, that the first
Interest Payment Date shall be April 15, 2008. Interest will be calculated on the basis of a 360-day year of twelve 30-day months. In certain circumstances, liquidated damages may be payable as provided in Section 6.01 of the Indenture.
Any such liquidated damages shall be payable in the same manner and on the same dates as the stated interest payable on this Security. 
 The
Holder of this Security is entitled to the benefits of the Exchange and Registration Rights Agreement. Pursuant to the Exchange and Registration Rights Agreement, the Company has agreed (i) to file the Exchange Registration Statement (as
defined in the Exchange and 

  

 A-5 

 
Registration Rights Agreement) as soon as practicable, but no later than 210 days after the Closing Date (as defined in the Exchange and Registration Rights
Agreement), (ii) to use its commercially reasonable efforts to cause such Exchange Registration Statement to become effective under the Securities Act as soon as practicable, but no later than 300 days after the Closing Date, and (iii) to
use its commercially reasonable efforts to commence and complete the Exchange Offer (as defined in the Exchange and Registration Rights Agreement) promptly, but no later than 45 days after such registration statement has become effective, hold the
Exchange Offer open for at least 30 days and exchange Exchange Securities (as defined in the Exchange and Registration Rights Agreement) for all Registrable Securities (as defined in the Exchange and Registration Rights Agreement) that have been
properly tendered and not withdrawn on or prior to the expiration of the Exchange Offer. If (i) on or prior to the time the Exchange Offer is completed existing SEC interpretations are changed such that debt securities or the related guarantee
received by holders other than Restricted Holders (as defined in the Exchange and Registration Rights Agreement) in the Exchange Offer for Registrable Securities (as defined in the Exchange and Registration Rights Agreement) are not or would not be,
upon receipt, transferable by each such holder without restriction under the Securities Act, (ii) the Exchange Offer is not completed within 345 days after the Closing Date or (iii) the Exchange Offer is not available to any Holder, then,
in each case, the Company is required to (a) as soon as practicable but no later than 60 days after the time such obligation to file arises, file a Shelf Registration Statement (as defined in the Exchange and Registration Rights Agreement) and
(b) use its commercially reasonable best efforts to cause the Shelf Registration Statement to become or be declared effective within 120 days after such Shelf Registration Statement is filed and to keep such Shelf Registration Statement
continuously effective until the earlier of two years after the date as of which the Shelf Registration Statement became or was declared effective or such time as there are no longer any Registrable Securities outstanding. If (i) the Company
fails to file the Exchange Registration Statement or the Shelf Registration Statement on or before the date specified for such filing, (ii) any of the Exchange Registration Statement or the Shelf Registration Statement is not declared effective
by the date specified for such effectiveness, (iii) the Company fails to complete the Exchange Offer within 45 after the effectiveness target date with respect to the Exchange Registration Statement, (iv) any of the Exchange Registration
Statement or the Shelf Registration Statement is declared effective but thereafter is withdrawn or ceases to be effective due to a stop order issued pursuant to the Securities Act suspending the effectiveness of such registration statement without
being succeeded by an additional registration statement filed and declared effective or (v) the Company requires Holders to refrain from disposing of their Registrable Securities under certain circumstances described in the Exchange and
Registration Rights Agreement and that suspension period exceeds 45 days in any one instance or 90 days in the aggregate during any consecutive 12 month period (each such event referred to in clauses (i) through (v), a “Registration
Default” and each period during which a Registration Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages for such Registration Default, subject to certain exceptions, special interest
(“Special Interest”) shall accrue at a per annum rate of 0.25% for the first 90 days of the Registration Default Period and at a per annum rate of 0.50% thereafter for the remaining portion of the Registration Default Period. 

2. Method of Payment. The Company will pay interest on the Securities (except defaulted interest), if any, to the persons in whose
name such Securities are registered at the close of business on the regular record date referred to on the facing page of this Security for 

  

 A-6 

 
such interest installment. In the event that the Securities or a portion thereof are called for redemption and the Redemption Date is subsequent to a regular
record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Securities will be paid upon presentation and surrender of such Securities as provided in the Indenture. The principal of and the
interest on the Securities shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose in accordance with
the Indenture. 
 3. Paying Agent and Registrar. Initially, Deutsche Bank Trust Company Americas, the Trustee, will act as
paying agent and Security Registrar. The Company may change or appoint any paying agent or Security Registrar without notice to any Securityholder. Holdco, Parent, the Company or any of their Subsidiaries may act in any such capacity. 
 4. Indenture. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the
Trust Indenture Act of 1939 (“TIA”) as in effect on the date the Indenture is qualified. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and TIA for a statement of such terms. The Securities
are unsecured general obligations of the Company and constitute the series designated on the face hereof as the “5.150% Senior Notes due 2010”, initially limited to $250,000,000 in aggregate principal amount. The Company will furnish to
any Securityholder upon written request and without charge a copy of the Base Indenture, the First Supplemental Indenture and the Fifth Supplemental Indenture. Requests may be made to: Covidien International Finance S.A., 4th Floor, 3b bd Prince
Henri, L-1724 Luxembourg, Attention: The Managing Directors. 
 5. Optional Redemption. The Securities may not be redeemed
at the option of the Company prior to the maturity date, except as provided in Article XIV of the Base Indenture, as amended. 
 The Company
shall not be required to make mandatory redemption or sinking fund payments with respect to the Securities. 
 6. Change of Control
Triggering Event. Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem this Security, the holder of this Security will have the right to require that the Company purchase all or a
portion, in $1,000 increments (provided that any remaining principal amount thereof shall be at least the minimum authorized denomination thereof), of this Security at a purchase price equal to 101% of the principal amount hereof plus accrued
and unpaid interest, if any, to the date of purchase. Within 30 days following the date upon which the Change of Control Triggering Event occurred, or at the Company’s option, prior to any Change of Control, but after the public announcement of
the Change of Control, the Company shall send, by first class mail, a notice to each Holder, with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer. 
 7. Denominations, Transfer, Exchange. The Securities are in registered form without coupons in the denominations of $2,000 or any
integral multiple of $1,000 in excess thereof. The transfer of Securities may be registered and Securities may be exchanged as provided in the Indenture. The Securities may be presented for exchange or for registration of transfer (duly endorsed or
with the form of transfer endorsed thereon duly executed if so required by the 

  

 A-7 

 
Company or the Security Registrar) at the office of the Security Registrar or at the office of any transfer agent designated by the Company for such purpose.
No service charge will be made for any registration of transfer or exchange, but a Securityholder may be required to pay any applicable taxes or other governmental charges. If the Securities are to be redeemed, the Company will not be required to:
(i) issue, register the transfer of, or exchange any Security during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of less than all of the outstanding Securities of the same series and
ending at the close of business on the day of such mailing; (ii) register the transfer of or exchange any Security of any series or portions thereof selected for redemption, in whole or in part, except the unredeemed portion of any such
Security being redeemed in part; nor (iii) register the transfer of or exchange a Security of any series between the applicable record date and the next succeeding Interest Payment Date. 
 8. Persons Deemed Owners. The registered Securityholder may be treated as its owner for all purposes. 
 9. Repayment to Holdco, Parent or the Company. Any funds or Governmental Obligations deposited with any paying agent or the Trustee, or then held
by Holdco, Parent or the Company, in trust for payment of principal of, premium, if any, or interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for at least one year after the
date upon which the principal of, premium, if any, or interest on such Securities shall have respectively become due and payable, shall be repaid to Holdco, Parent or the Company, as applicable, or (if then held by Holdco, Parent or the Company)
shall be discharged from such trust. After return to the Company, Parent or Holdco, Holders entitled to the money or securities must look to the Company, Parent or Holdco, as applicable, for payment as unsecured general creditors. 
 10. Amendments, Supplements and Waivers. The Indenture contains provisions permitting the Company, Parent, Holdco and the Trustee, with
the consent of the holders of not less than a majority in aggregate principal amount of the Outstanding Securities to enter into supplemental indentures for the purpose of adding, changing or eliminating any provisions to the Base Indenture or
supplemental indenture or indentures or of modifying in any manner not covered elsewhere in the Base Indenture the rights of the holders of the Securities of such series; provided, however, that no such supplemental indenture, without
the consent of the holders of each Security then Outstanding and affected thereby, shall: (i) extend a fixed maturity of or any installment of principal of any Securities of any series or reduce the principal amount thereof, or reduce the
amount of principal of any original issue discount security that would be due and payable upon declaration of acceleration of the maturity thereof; (ii) reduce the rate of or extend the time for payment of interest of any Security of any
series; (iii) reduce the premium payable upon the redemption of any Security; (iv) make any Security payable in Currency other than that stated in the Security; (v) impair the right to institute suit for the enforcement of any payment
on or after the fixed maturity thereof (or in the case or redemption, on or after the redemption date); or (vi) reduce the percentage of Securities, the holders of which are required to consent to any such supplemental indenture or indentures.
The Base Indenture also contains provisions permitting the holders of not less than a majority in aggregate principal amount of the Outstanding securities of each series affected thereby, on behalf of all of the holders of the securities of such
series, to waive any past Default under the Base Indenture, and its 

  

 A-8 

 
consequences, except a Default in the payment of the principal of, premium, if any, or interest on any security of such series or a Default in respect of a
covenant or provision of the Base Indenture that cannot be modified or amended without the consent of the holder of each Outstanding security of such affected series. Any such consent or waiver by the registered Securityholder shall be conclusive
and binding upon such holder and upon all future holders and owners of this Security and of any Security issued in exchange for this Security or in place hereof (whether by registration of transfer or otherwise), irrespective of whether or not any
notation of such consent or waiver is made upon this Security. 
 11. Defaults and Remedies. If an Event of Default with
respect to the securities of a series issued pursuant to the Base Indenture occurs and is continuing, the Trustee or the holders of at least 25% in aggregate principal amount of the Securities of such series then Outstanding, by notice in writing to
the Company, Parent and Holdco (and to the Trustee if notice is given by such holders), may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately. Subject to the terms of the Indenture, if an
Event of Default under the Indenture shall occur and be continuing, the Trustee will be under no obligation to exercise any of its rights or powers under the Indenture at the request or direction of any of the holders, unless such holders have
offered the Trustee indemnity satisfactory to it. Upon satisfaction of certain conditions set forth in the Indenture, the holders of a majority in principal amount of the Outstanding securities of a series issued pursuant to the Base Indenture will
have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the securities of such series. 
 12. Trustee, Paying Agent and Security Registrar May Hold Securities. The Trustee, subject to certain limitations imposed by the TIA, or any
paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not Trustee, paying agent or Security Registrar. 
 13. No Recourse Against Others. No recourse under or upon any obligation, covenant or agreement of the Indenture, or of any Security, or
for any claim based thereon or otherwise in respect hereof or thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of Holdco, Parent or the Company or of any predecessor or successor
corporation, either directly or through Holdco, Parent or the Company or any such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise;
it being expressly understood that the Indenture and the obligations issued hereunder and thereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators,
shareholders, officers or directors as such, of Holdco, Parent or the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness authorized by the Indenture, or under or by reason of the
obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity or by constitution or statute, of,
and any and all such rights and claims against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness authorized by the Indenture, or under or by reason of the obligations, covenants or
agreements contained in the Indenture or in the Securities or implied therefrom, are 

  

 A-9 

 
hereby expressly waived and released as a condition of, and as a consideration for, the acceptance of the Securities. 
 14. Discharge of Indenture. The Indenture contains certain provisions pertaining to defeasance, which provisions shall for all purposes
have the same effect as if set forth herein. 
 15. Authentication. This Security shall not be valid until the Trustee signs
the certificate of authentication attached to the other side of this Security. 
 16. Guarantees. All payments by the Company under
the Indenture and this Security are jointly and severally, fully and unconditionally guaranteed to the holder of this Security by Holdco and Parent, as provided in the related Guarantee and the Indenture. 
 17. Additional Amounts. The Company, Parent and Holdco are obligated to pay Additional Amounts on this Security to the extent provided in Article
XIV of the Indenture. 
 18. Abbreviations. Customary abbreviations may be used in the name of a Securityholder or an
assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

19. Governing Law. The Base Indenture, the First Supplemental Indenture, the Fifth Supplemental Indenture and this Security (and the
Guarantee hereon) shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said State. 
  

 A-10 

 ASSIGNMENT FORM 
 To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to 
  
  
 (Insert assignee’s soc. sec. or tax I.D. no.)

  
  
  
  
  
  
  
  
 (Print or type assignee’s name, address and zip
code) 
  

			
	and irrevocably appoint	  	  

 agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.

  
  
 Date:                      
  

			
	Your Signature:	 	  

	(Sign exactly as your name appears on the face of this Security)

 Signature
Guarantee:                                       
  
  

 A-11 

 OPTION OF HOLDER TO ELECT PURCHASE 
 If you want to elect to have this Security purchased by the Company pursuant to Section 1.3(3) of the First Supplemental Indenture, check the box:

  ̈  1.3(3) Change of Control Triggering Event 
 If you want to elect to have only part of this Security purchased by the Company pursuant to Section 1.3(3) of the First Supplemental
Indenture, state the amount: $            . 
  

			
	 Date:                     
	 	Your Signature:
		 	(Sign exactly as your name appears
		 	on the other side of the Security)

 Tax I.D. number 
  

			
	 Signature Guarantee:
	 	  

		 	(Signature must be guaranteed by a participant in a recognized signature guarantee medallion program)

  

 A-12 

 ANNEX B 
 FORM OF 5.450% SENIOR NOTES 
 [Insert the Private Placement Legend and/or the Global Security
legend, as applicable] 
 5.450% SENIOR NOTES DUE 2012 
  

			
	No. [    ]	  	$[            ]
	CUSIP No. [            ]	  	

 COVIDIEN INTERNATIONAL FINANCE S.A. 
 promises to pay to Cede & Co. or registered assigns, the principal sum of [            ] Dollars on October 15, 2012. 
 Interest Payment Dates: April 15 and October 15 
 Record Dates:
April 1 and October 1 
 Each holder of this Security (as defined below), by accepting the same, agrees to and shall be bound by
the provisions hereof and of the Indenture described herein, and authorizes and directs the Trustee described herein on such holder’s behalf to be bound by such provisions. Each holder of this Security hereby waives all notice of the acceptance
of the provisions contained herein and in the Indenture and waives reliance by such holder upon said provisions. 
 This Security shall not
be entitled to any benefit under the Indenture, or be valid or become obligatory for any purpose, until the Certificate of Authentication hereon shall have been signed by or on behalf of the Trustee. The provisions of this Security are continued on
the reverse side hereof, and such continued provisions shall for all purposes have the same effect as though fully set forth at this place. 
 IN WITNESS
WHEREOF, the Company has caused this instrument to be signed in accordance with Section 2.04 of the Indenture. 
 Date:
[            ] 
  

			
	 COVIDIEN INTERNATIONAL FINANCE S.A.

	
	  

	 Name:
	 	
	 Title:
	 	
	
	[If second signature is applicable:]
	
	  

	Name:	 	

  

 B-1 

	
	Title:

  

 B-2 

 CERTIFICATE OF AUTHENTICATION 
 This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 
  

			
	 DEUTSCHE BANK TRUST COMPANY
 AMERICAS, as
Trustee

		
	By:	 	  

		 	Authorized Signatory
		
	By:	 	  

		
		 	Authorized Signatory
		
	Dated:	 	[            ]

  

 B-3 

 GUARANTEE 
 For value received, each of Covidien plc and Covidien Ltd. hereby jointly and severally, absolutely, unconditionally and irrevocably guarantees to the holder of this Security the payment of principal of, premium, if
any, and interest on, the Security upon which this Guarantee is set forth in the amounts and at the time when due and payable whether by declaration thereof, or otherwise, and interest on the overdue principal and interest, if any, of such Security,
if lawful, to the holder of such Security and the Trustee on behalf of the Holders, all in accordance with and subject to the terms and limitations of such Security and Article XV of the Indenture. This Guarantee will not become effective until the
Trustee or Authenticating Agent duly executes the certificate of authentication on this Security. This Guarantee shall be governed by and construed in accordance with the laws of the State of New York, without regard to conflict of law principles
thereof. 
 Dated: [            ] 
  

			
	COVIDIEN LTD.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	 PRESENT when the COMMON SEAL of
 COVIDIEN PLC
was affixed hereto

	
	  

	Director	 	
	
	  

	Secretary	 	

  

 B-4 

 Covidien International Finance S.A. 
 5.450% Senior Notes due 2012 
 This security is one of a duly authorized series of debt
securities of Covidien International Finance S.A., a Luxembourg company (the “Company”), issued or to be issued in one or more series under and pursuant to an Indenture for the Company’s unsubordinated debt securities, dated as of
October 22, 2007 (the “Base Indenture”), duly executed and delivered by and among the Company, Covidien Ltd. (“Parent”) and Deutsche Bank Trust Company Americas (the “Trustee”), as supplemented by the Second
Supplemental Indenture, dated as of October 22, 2007 (the “Second Supplemental Indenture”), by and among the Company, Parent and the Trustee, and the Fifth Supplemental Indenture, dated as of June 4, 2009 (the “Fifth
Supplemental Indenture”), by and among the Company, Parent, Covidien plc (“Holdco”) and the Trustee. The Base Indenture as supplemented and amended by the Second Supplemental Indenture and the Fifth Supplemental Indenture is referred
to herein as the “Indenture.” By the terms of the Base Indenture, the debt securities issuable thereunder are issuable in series that may vary as to amount, date of maturity, rate of interest and in other respects as provided in the Base
Indenture. This security is one of the series designated on the face hereof (individually, a “Security,” and collectively, the “Securities”), and reference is hereby made to the Indenture for a description of the rights,
limitations of rights, obligations, duties and immunities of the Trustee, the Company, Parent, Holdco and the holders of the Securities (the “Securityholders”). Capitalized terms used herein and not otherwise defined shall have the
meanings given them in the Base Indenture or the Second Supplemental Indenture, as applicable, in each case as amended by the Fifth Supplemental Indenture. 
 1. Interest. The Company promises to pay interest on the principal amount of this Security at an annual rate of 5.450%. The Company will pay interest semi-annually on April 15 and October 15 of
each year (each such day, an “Interest Payment Date”). If any Interest Payment Date, redemption date or maturity date of this Security is not a Business Day, then payment of interest or principal (and premium, if any) shall be made on the
next succeeding Business Day with the same force and effect as if made on the date such payment was due, and no interest shall accrue for the period after such date to the date of such payment on the next succeeding Business Day. Interest on the
Securities will accrue from the most recent date to which interest has been paid or duly provided for or, if no interest has been paid, from the date of issuance; provided that, if there is no existing Default in the payment of interest, and if this
Security is authenticated between a regular record date referred to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date; and provided, further, that the first
Interest Payment Date shall be April 15, 2008. Interest will be calculated on the basis of a 360-day year of twelve 30-day months. In certain circumstances, liquidated damages may be payable as provided in Section 6.01 of the Indenture.
Any such liquidated damages shall be payable in the same manner and on the same dates as the stated interest payable on this Security. 
 The
Holder of this Security is entitled to the benefits of the Exchange and Registration Rights Agreement. Pursuant to the Exchange and Registration Rights Agreement, the Company has agreed (i) to file the Exchange Registration Statement (as
defined in the Exchange and 

  

 B-5 

 
Registration Rights Agreement) as soon as practicable, but no later than 210 days after the Closing Date (as defined in the Exchange and Registration Rights
Agreement), (ii) to use its commercially reasonable efforts to cause such Exchange Registration Statement to become effective under the Securities Act as soon as practicable, but no later than 300 days after the Closing Date, and (iii) to
use its commercially reasonable efforts to commence and complete the Exchange Offer (as defined in the Exchange and Registration Rights Agreement) promptly, but no later than 45 days after such registration statement has become effective, hold the
Exchange Offer open for at least 30 days and exchange Exchange Securities (as defined in the Exchange and Registration Rights Agreement) for all Registrable Securities (as defined in the Exchange and Registration Rights Agreement) that have been
properly tendered and not withdrawn on or prior to the expiration of the Exchange Offer. If (i) on or prior to the time the Exchange Offer is completed existing SEC interpretations are changed such that debt securities or the related guarantee
received by holders other than Restricted Holders (as defined in the Exchange and Registration Rights Agreement) in the Exchange Offer for Registrable Securities (as defined in the Exchange and Registration Rights Agreement) are not or would not be,
upon receipt, transferable by each such holder without restriction under the Securities Act, (ii) the Exchange Offer is not completed within 345 days after the Closing Date or (iii) the Exchange Offer is not available to any Holder, then,
in each case, the Company is required to (a) as soon as practicable but no later than 60 days after the time such obligation to file arises, file a Shelf Registration Statement (as defined in the Exchange and Registration Rights Agreement) and
(b) use its commercially reasonable best efforts to cause the Shelf Registration Statement to become or be declared effective within 120 days after such Shelf Registration Statement is filed and to keep such Shelf Registration Statement
continuously effective until the earlier of two years after the date as of which the Shelf Registration Statement became or was declared effective or such time as there are no longer any Registrable Securities outstanding. If (i) the Company
fails to file the Exchange Registration Statement or the Shelf Registration Statement on or before the date specified for such filing, (ii) any of the Exchange Registration Statement or the Shelf Registration Statement is not declared effective
by the date specified for such effectiveness, (iii) the Company fails to complete the Exchange Offer within 45 after the effectiveness target date with respect to the Exchange Registration Statement, (iv) any of the Exchange Registration
Statement or the Shelf Registration Statement is declared effective but thereafter is withdrawn or ceases to be effective due to a stop order issued pursuant to the Securities Act suspending the effectiveness of such registration statement without
being succeeded by an additional registration statement filed and declared effective or (v) the Company requires Holders to refrain from disposing of their Registrable Securities under certain circumstances described in the Exchange and
Registration Rights Agreement and that suspension period exceeds 45 days in any one instance or 90 days in the aggregate during any consecutive 12 month period (each such event referred to in clauses (i) through (v), a “Registration
Default” and each period during which a Registration Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages for such Registration Default, subject to certain exceptions, special interest
(“Special Interest”) shall accrue at a per annum rate of 0.25% for the first 90 days of the Registration Default Period and at a per annum rate of 0.50% thereafter for the remaining portion of the Registration Default Period. 

2. Method of Payment. The Company will pay interest on the Securities (except defaulted interest), if any, to the persons in whose
name such Securities are registered at the close of business on the regular record date referred to on the facing page of this Security for 

  

 B-6 

 
such interest installment. In the event that the Securities or a portion thereof are called for redemption and the Redemption Date is subsequent to a regular
record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Securities will be paid upon presentation and surrender of such Securities as provided in the Indenture. The principal of and the
interest on the Securities shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose in accordance with
the Indenture. 
 3. Paying Agent and Registrar. Initially, Deutsche Bank Trust Company Americas, the Trustee, will act as
paying agent and Security Registrar. The Company may change or appoint any paying agent or Security Registrar without notice to any Securityholder. Holdco, Parent, the Company or any of their Subsidiaries may act in any such capacity. 
 4. Indenture. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the
Trust Indenture Act of 1939 (“TIA”) as in effect on the date the Indenture is qualified. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and TIA for a statement of such terms. The Securities
are unsecured general obligations of the Company and constitute the series designated on the face hereof as the “5.450% Senior Notes due 2012”, initially limited to $500,000,000 in aggregate principal amount. The Company will furnish to
any Securityholder upon written request and without charge a copy of the Base Indenture, the Second Supplemental Indenture and the Fifth Supplemental Indenture. Requests may be made to: Covidien International Finance S.A., 4th Floor, 3b bd Prince
Henri, L-1724 Luxembourg, Attention: The Managing Directors. 
 5. Optional Redemption. The Securities will be subject to
redemption at the option of the Company on any date prior to the maturity date, in whole or from time to time in part, in $1,000 increments (provided that any remaining principal amount thereof shall be at least the minimum authorized
denomination thereof), on written notice given to the Securityholders thereof not less than 30 days nor more than 90 days prior to the date fixed for redemption in such notice (the “Redemption Date”), at a redemption price equal to the
greater of (i) 100% of the principal amount of such Securities to be redeemed and (ii) as determined by the Quotation Agent and delivered to the Trustee, the sum of the present values of the remaining scheduled payments of principal and
interest thereon due on any date after the Redemption Date (excluding the portion of interest that will be accrued and unpaid to and including the Redemption Date) discounted from their scheduled date of payment to the Redemption Date (assuming a
360-day year consisting of twelve 30-day months) at the Adjusted Redemption Treasury Rate plus 20 basis points (such greater amount is referred to herein as the “Redemption Price”), plus, in either the case of clause (i) or clause
(ii), accrued and unpaid interest and Special Interest, if any, thereon to the Redemption Date. This Security is also subject to redemption to the extent provided in Article XIV of the Indenture. 
 If the giving of the notice of redemption is completed as provided in the Indenture, interest on such Securities or portions of Securities shall cease to
accrue on and after the Redemption Date, unless the Company shall default in the payment of such Redemption Price and accrued interest with respect to any such Security or portion thereof. 
  

 B-7 

 The Company shall not be required to make mandatory redemption or sinking fund payments with respect to
the Securities. 
 6. Change of Control Triggering Event. Upon the occurrence of a Change of Control Triggering Event, unless the
Company has exercised its right to redeem this Security, the holder of this Security will have the right to require that the Company purchase all or a portion, in $1,000 increments (provided that any remaining principal amount thereof shall
be at least the minimum authorized denomination thereof), of this Security at a purchase price equal to 101% of the principal amount hereof plus accrued and unpaid interest, if any, to the date of purchase. Within 30 days following the date upon
which the Change of Control Triggering Event occurred, or at the Company’s option, prior to any Change of Control, but after the public announcement of the Change of Control, the Company shall send, by first class mail, a notice to each Holder,
with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer. 
 7. Denominations, Transfer,
Exchange. The Securities are in registered form without coupons in the denominations of $2,000 or any integral multiple of $1,000 in excess thereof. The transfer of Securities may be registered and Securities may be exchanged as provided in
the Indenture. The Securities may be presented for exchange or for registration of transfer (duly endorsed or with the form of transfer endorsed thereon duly executed if so required by the Company or the Security Registrar) at the office of the
Security Registrar or at the office of any transfer agent designated by the Company for such purpose. No service charge will be made for any registration of transfer or exchange, but a Securityholder may be required to pay any applicable taxes or
other governmental charges. If the Securities are to be redeemed, the Company will not be required to: (i) issue, register the transfer of, or exchange any Security during a period beginning at the opening of business 15 days before the day of
mailing of a notice of redemption of less than all of the outstanding Securities of the same series and ending at the close of business on the day of such mailing; (ii) register the transfer of or exchange any Security of any series or portions
thereof selected for redemption, in whole or in part, except the unredeemed portion of any such Security being redeemed in part; nor (iii) register the transfer of or exchange a Security of any series between the applicable record date and the
next succeeding Interest Payment Date. 
 8. Persons Deemed Owners. The registered Securityholder may be treated as its
owner for all purposes. 
 9. Repayment to Holdco, Parent or the Company. Any funds or Governmental Obligations deposited with any
paying agent or the Trustee, or then held by Holdco, Parent or the Company, in trust for payment of principal of, premium, if any, or interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such
Securities for at least one year after the date upon which the principal of, premium, if any, or interest on such Securities shall have respectively become due and payable, shall be repaid to Holdco, Parent or the Company, as applicable, or (if then
held by Holdco, Parent or the Company) shall be discharged from such trust. After return to the Company, Parent or Holdco, Holders entitled to the money or securities must look to the Company or Parent, as applicable, for payment as unsecured
general creditors. 
  

 B-8 

 10. Amendments, Supplements and Waivers. The Indenture contains provisions permitting
the Company, Parent, Holdco and the Trustee, with the consent of the holders of not less than a majority in aggregate principal amount of the Outstanding Securities to enter into supplemental indentures for the purpose of adding, changing or
eliminating any provisions to the Base Indenture or supplemental indenture or indentures or of modifying in any manner not covered elsewhere in the Base Indenture the rights of the holders of the Securities of such series; provided,
however, that no such supplemental indenture, without the consent of the holders of each Security then Outstanding and affected thereby, shall: (i) extend a fixed maturity of or any installment of principal of any Securities of any
series or reduce the principal amount thereof, or reduce the amount of principal of any original issue discount security that would be due and payable upon declaration of acceleration of the maturity thereof; (ii) reduce the rate of or extend
the time for payment of interest of any Security of any series; (iii) reduce the premium payable upon the redemption of any Security; (iv) make any Security payable in Currency other than that stated in the Security; (v) impair the
right to institute suit for the enforcement of any payment on or after the fixed maturity thereof (or in the case or redemption, on or after the redemption date); or (vi) reduce the percentage of Securities, the holders of which are required to
consent to any such supplemental indenture or indentures. The Base Indenture also contains provisions permitting the holders of not less than a majority in aggregate principal amount of the Outstanding securities of each series affected thereby, on
behalf of all of the holders of the securities of such series, to waive any past Default under the Base Indenture, and its consequences, except a Default in the payment of the principal of, premium, if any, or interest on any security of such series
or a Default in respect of a covenant or provision of the Base Indenture that cannot be modified or amended without the consent of the holder of each Outstanding security of such affected series. Any such consent or waiver by the registered
Securityholder shall be conclusive and binding upon such holder and upon all future holders and owners of this Security and of any Security issued in exchange for this Security or in place hereof (whether by registration of transfer or otherwise),
irrespective of whether or not any notation of such consent or waiver is made upon this Security. 
 11. Defaults and
Remedies. If an Event of Default with respect to the securities of a series issued pursuant to the Base Indenture occurs and is continuing, the Trustee or the holders of at least 25% in aggregate principal amount of the Securities of such
series then Outstanding, by notice in writing to the Company, Parent and Holdco (and to the Trustee if notice is given by such holders), may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately.
Subject to the terms of the Indenture, if an Event of Default under the Indenture shall occur and be continuing, the Trustee will be under no obligation to exercise any of its rights or powers under the Indenture at the request or direction of any
of the holders, unless such holders have offered the Trustee indemnity satisfactory to it. Upon satisfaction of certain conditions set forth in the Indenture, the holders of a majority in principal amount of the Outstanding securities of a series
issued pursuant to the Base Indenture will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the
securities of such series. 
 12. Trustee, Paying Agent and Security Registrar May Hold Securities. The Trustee, subject to certain
limitations imposed by the TIA, or any paying agent or Security Registrar, in 

  

 B-9 

 
its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not Trustee, paying agent
or Security Registrar. 
 13. No Recourse Against Others. No recourse under or upon any obligation, covenant or agreement of
the Indenture, or of any Security, or for any claim based thereon or otherwise in respect hereof or thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of Holdco, Parent or the Company
or of any predecessor or successor corporation, either directly or through Holdco, Parent or the Company or any such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any
assessment or penalty or otherwise; it being expressly understood that the Indenture and the obligations issued hereunder and thereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall
be incurred by, the incorporators, shareholders, officers or directors as such, of Holdco, Parent or the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness authorized by the Indenture,
or under or by reason of the obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity or by
constitution or statute, of, and any and all such rights and claims against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness authorized by the Indenture, or under or by reason of the
obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the acceptance of the Securities. 
 14. Discharge of Indenture. The Indenture contains certain provisions pertaining to defeasance, which provisions shall for all purposes
have the same effect as if set forth herein. 
 15. Authentication. This Security shall not be valid until the Trustee signs
the certificate of authentication attached to the other side of this Security. 
 16. Guarantees. All payments by the Company under
the Indenture and this Security are jointly and severally, fully and unconditionally guaranteed to the holder of this Security by Holdco and Parent, as provided in the related Guarantee and the Indenture. 
 17. Additional Amounts. The Company, Parent and Holdco are obligated to pay Additional Amounts on this Security to the extent provided in Article
XIV of the Indenture. 
 18. Abbreviations. Customary abbreviations may be used in the name of a Securityholder or an
assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

19. Governing Law. The Base Indenture, the Second Supplemental Indenture, the Fifth Supplemental Indenture and this Security (and the
Guarantee hereon) shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said State. 
  

 B-10 

 ASSIGNMENT FORM 
 To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to 
  

	
	  

	 (Insert assignee’s soc. sec. or tax I.D. no.)

	
	  

	
	  

	
	  

	
	  

	(Print or type assignee’s name, address and zip code)

			
	and irrevocably appoint	 	  

	agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.
	
	  

  

			
	 Date:
	 	  

  

			
	 Your Signature:
	 	  

	(Sign exactly as your name appears on the face of this Security)

  

			
	 Signature Guarantee:
	 	  

  

 B-11 

 OPTION OF HOLDER TO ELECT PURCHASE 
 If you want to elect to have this Security purchased by the Company pursuant to Section 1.3(3) of the Second Supplemental Indenture, check the box:

  ̈  1.3(3) Change of Control Triggering Event 
 If you want to elect to have only part of this Security purchased by the Company pursuant to Section 1.3(3) of the Second Supplemental
Indenture, state the amount: $            . 
  

			
	 Date:                     
	 	Your Signature:
		 	(Sign exactly as your name appears
		 	on the other side of the Security)

 Tax I.D. number 
  

			
	 Signature Guarantee:
	 	  

		 	(Signature must be guaranteed by a participant in a recognized signature guarantee medallion program)

  

 B-12 

 ANNEX C 
 FORM OF 6.000% SENIOR NOTES 
 [Insert the Private Placement Legend and/or the Global Security
legend, as applicable] 
 6.000% SENIOR NOTES DUE 2017 
  

			
	 No. [    ]
	  	$[             ]
	 CUSIP No. [            ]
	  	

 COVIDIEN INTERNATIONAL FINANCE S.A. 
 promises to pay to Cede & Co. or registered assigns, the principal sum of [            ] Dollars on October 15, 2017. 
 Interest Payment Dates: April 15 and October 15 
 Record Dates:
April 1 and October 1 
 Each holder of this Security (as defined below), by accepting the same, agrees to and shall be bound by the
provisions hereof and of the Indenture described herein, and authorizes and directs the Trustee described herein on such holder’s behalf to be bound by such provisions. Each holder of this Security hereby waives all notice of the acceptance of
the provisions contained herein and in the Indenture and waives reliance by such holder upon said provisions. 
 This Security shall not be
entitled to any benefit under the Indenture, or be valid or become obligatory for any purpose, until the Certificate of Authentication hereon shall have been signed by or on behalf of the Trustee. The provisions of this Security are continued on the
reverse side hereof, and such continued provisions shall for all purposes have the same effect as though fully set forth at this place. 
 IN WITNESS
WHEREOF, the Company has caused this instrument to be signed in accordance with Section 2.04 of the Indenture. 
 Date:
[            ] 
  

	
	COVIDIEN INTERNATIONAL FINANCE S.A.
	
	  

	Name:
	Title:
	
	[If second signature is applicable:]
	
	  

	Name:

  

 C-1 

	
	Title:

  

 C-2 

 CERTIFICATE OF AUTHENTICATION 
 This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 
  

			
	 DEUTSCHE BANK TRUST COMPANY
 AMERICAS, as
Trustee

		
	By:	 	  

		 	Authorized Signatory
		
	By:	 	  

		 	Authorized Signatory
		
	Dated:	 	[            ]

  

 C-3 

 GUARANTEE 
 For value received, each of Covidien plc and Covidien Ltd. hereby jointly and severally, absolutely, unconditionally and irrevocably guarantees to the holder of this Security the payment of principal of, premium, if
any, and interest on, the Security upon which this Guarantee is set forth in the amounts and at the time when due and payable whether by declaration thereof, or otherwise, and interest on the overdue principal and interest, if any, of such Security,
if lawful, to the holder of such Security and the Trustee on behalf of the Holders, all in accordance with and subject to the terms and limitations of such Security and Article XV of the Indenture. This Guarantee will not become effective until the
Trustee or Authenticating Agent duly executes the certificate of authentication on this Security. This Guarantee shall be governed by and construed in accordance with the laws of the State of New York, without regard to conflict of law principles
thereof. 
 Dated: [            ] 
  

			
	COVIDIEN LTD.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	 PRESENT when the COMMON SEAL of
 COVIDIEN PLC
was affixed hereto

	
	  

	Director
	
	  

	Secretary

  

 C-4 

 Covidien International Finance S.A. 
 6.000% Senior Notes due 2017 
 This security is one of a duly authorized series of debt
securities of Covidien International Finance S.A., a Luxembourg company (the “Company”), issued or to be issued in one or more series under and pursuant to an Indenture for the Company’s unsubordinated debt securities, dated as of
October 22, 2007 (the “Base Indenture”), duly executed and delivered by and among the Company, Covidien Ltd. (“Parent”) and Deutsche Bank Trust Company Americas (the “Trustee”), as supplemented by the Third
Supplemental Indenture, dated as of October 22, 2007 (the “Third Supplemental Indenture”), by and among the Company, Parent and the Trustee, and the Fifth Supplemental Indenture, dated as of June 4, 2009, by and among the
Company, Parent, Covidien plc (“Holdco”) and the Trustee. The Base Indenture as supplemented and amended by the Third Supplemental Indenture and the Fifth Supplemental Indenture is referred to herein as the “Indenture.” By the
terms of the Base Indenture, the debt securities issuable thereunder are issuable in series that may vary as to amount, date of maturity, rate of interest and in other respects as provided in the Base Indenture. This security is one of the series
designated on the face hereof (individually, a “Security,” and collectively, the “Securities”), and reference is hereby made to the Indenture for a description of the rights, limitations of rights, obligations, duties and
immunities of the Trustee, the Company, Parent, Holdco and the holders of the Securities (the “Securityholders”). Capitalized terms used herein and not otherwise defined shall have the meanings given them in the Base Indenture or the Third
Supplemental Indenture, as applicable, in each case as amended by the Fifth Supplemental Indenture. 
 1. Interest. The Company
promises to pay interest on the principal amount of this Security at an annual rate of 6.000%. The Company will pay interest semi-annually on April 15 and October 15 of each year (each such day, an “Interest Payment Date”). If
any Interest Payment Date, redemption date or maturity date of this Security is not a Business Day, then payment of interest or principal (and premium, if any) shall be made on the next succeeding Business Day with the same force and effect as if
made on the date such payment was due, and no interest shall accrue for the period after such date to the date of such payment on the next succeeding Business Day. Interest on the Securities will accrue from the most recent date to which interest
has been paid or duly provided for or, if no interest has been paid, from the date of issuance; provided that, if there is no existing Default in the payment of interest, and if this Security is authenticated between a regular record date referred
to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date; and provided, further, that the first Interest Payment Date shall be April 15, 2008. Interest will be
calculated on the basis of a 360-day year of twelve 30-day months. In certain circumstances, liquidated damages may be payable as provided in Section 6.01 of the Indenture. Any such liquidated damages shall be payable in the same manner and on
the same dates as the stated interest payable on this Security. 
 The Holder of this Security is entitled to the benefits of the Exchange
and Registration Rights Agreement. Pursuant to the Exchange and Registration Rights Agreement, the Company has agreed (i) to file the Exchange Registration Statement (as defined in the Exchange and Registration Rights Agreement) as soon as
practicable, but no later than 210 days after the Closing Date (as defined in the Exchange and Registration Rights Agreement), (ii) to use its 

  

 C-5 

 
commercially reasonable efforts to cause such Exchange Registration Statement to become effective under the Securities Act as soon as practicable, but no
later than 300 days after the Closing Date, and (iii) to use its commercially reasonable efforts to commence and complete the Exchange Offer (as defined in the Exchange and Registration Rights Agreement) promptly, but no later than 45 days
after such registration statement has become effective, hold the Exchange Offer open for at least 30 days and exchange Exchange Securities (as defined in the Exchange and Registration Rights Agreement) for all Registrable Securities (as defined in
the Exchange and Registration Rights Agreement) that have been properly tendered and not withdrawn on or prior to the expiration of the Exchange Offer. If (i) on or prior to the time the Exchange Offer is completed existing SEC interpretations
are changed such that debt securities or the related guarantee received by holders other than Restricted Holders (as defined in the Exchange and Registration Rights Agreement) in the Exchange Offer for Registrable Securities (as defined in the
Exchange and Registration Rights Agreement) are not or would not be, upon receipt, transferable by each such holder without restriction under the Securities Act, (ii) the Exchange Offer is not completed within 345 days after the Closing Date or
(iii) the Exchange Offer is not available to any Holder, then, in each case, the Company is required to (a) as soon as practicable but no later than 60 days after the time such obligation to file arises, file a Shelf Registration Statement
(as defined in the Exchange and Registration Rights Agreement) and (b) use its commercially reasonable best efforts to cause the Shelf Registration Statement to become or be declared effective within 120 days after such Shelf Registration
Statement is filed and to keep such Shelf Registration Statement continuously effective until the earlier of two years after the date as of which the Shelf Registration Statement became or was declared effective or such time as there are no longer
any Registrable Securities outstanding. If (i) the Company fails to file the Exchange Registration Statement or the Shelf Registration Statement on or before the date specified for such filing, (ii) any of the Exchange Registration
Statement or the Shelf Registration Statement is not declared effective by the date specified for such effectiveness, (iii) the Company fails to complete the Exchange Offer within 45 after the effectiveness target date with respect to the
Exchange Registration Statement, (iv) any of the Exchange Registration Statement or the Shelf Registration Statement is declared effective but thereafter is withdrawn or ceases to be effective due to a stop order issued pursuant to the
Securities Act suspending the effectiveness of such registration statement without being succeeded by an additional registration statement filed and declared effective or (v) the Company requires Holders to refrain from disposing of their
Registrable Securities under certain circumstances described in the Exchange and Registration Rights Agreement and that suspension period exceeds 45 days in any one instance or 90 days in the aggregate during any consecutive 12 month period (each
such event referred to in clauses (i) through (v), a “Registration Default” and each period during which a Registration Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages
for such Registration Default, subject to certain exceptions, special interest (“Special Interest”) shall accrue at a per annum rate of 0.25% for the first 90 days of the Registration Default Period and at a per annum rate of 0.50%
thereafter for the remaining portion of the Registration Default Period. 
 2. Method of Payment. The Company will pay
interest on the Securities (except defaulted interest), if any, to the persons in whose name such Securities are registered at the close of business on the regular record date referred to on the facing page of this Security for such interest
installment. In the event that the Securities or a portion thereof are called for redemption and the Redemption Date is subsequent to a regular record date with respect to any 

  

 C-6 

 
Interest Payment Date and prior to such Interest Payment Date, interest on such Securities will be paid upon presentation and surrender of such Securities as
provided in the Indenture. The principal of and the interest on the Securities shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or agency of the
Company maintained for that purpose in accordance with the Indenture. 
 3. Paying Agent and Registrar. Initially, Deutsche
Bank Trust Company Americas, the Trustee, will act as paying agent and Security Registrar. The Company may change or appoint any paying agent or Security Registrar without notice to any Securityholder. Holdco, Parent, the Company or any of their
Subsidiaries may act in any such capacity. 
 4. Indenture. The terms of the Securities include those stated in the
Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (“TIA”) as in effect on the date the Indenture is qualified. The Securities are subject to all such terms, and Securityholders are referred to
the Indenture and TIA for a statement of such terms. The Securities are unsecured general obligations of the Company and constitute the series designated on the face hereof as the “6.000% Senior Notes due 2017”, initially limited to
$1,150,000,000 in aggregate principal amount. The Company will furnish to any Securityholder upon written request and without charge a copy of the Base Indenture, the Third Supplemental Indenture and the Fifth Supplemental Indenture. Requests may be
made to: Covidien International Finance S.A., 4th Floor, 3b bd Prince Henri, L-1724 Luxembourg, Attention: The Managing Directors. 
 5. Optional Redemption. The Securities will be subject to redemption at the option of the Company on any date prior to the maturity date, in whole or from time to time in part, in $1,000 increments (provided that any
remaining principal amount thereof shall be at least the minimum authorized denomination thereof), on written notice given to the Securityholders thereof not less than 30 days nor more than 90 days prior to the date fixed for redemption in such
notice (the “Redemption Date”), at a redemption price equal to the greater of (i) 100% of the principal amount of such Securities to be redeemed and (ii) as determined by the Quotation Agent and delivered to the Trustee, the sum
of the present values of the remaining scheduled payments of principal and interest thereon due on any date after the Redemption Date (excluding the portion of interest that will be accrued and unpaid to and including the Redemption Date) discounted
from their scheduled date of payment to the Redemption Date (assuming a 360-day year consisting of twelve 30-day months) at the Adjusted Redemption Treasury Rate plus 25 basis points (such greater amount is referred to herein as the “Redemption
Price”), plus, in either the case of clause (i) or clause (ii), accrued and unpaid interest and Special Interest, if any, thereon to the Redemption Date. This Security is also subject to redemption to the extent provided in Article XIV of
the Indenture. 
 If the giving of the notice of redemption is completed as provided in the Indenture, interest on such Securities or
portions of Securities shall cease to accrue on and after the Redemption Date, unless the Company shall default in the payment of such Redemption Price and accrued interest with respect to any such Security or portion thereof. 
 The Company shall not be required to make mandatory redemption or sinking fund payments with respect to the Securities. 
  

 C-7 

 6. Change of Control Triggering Event. Upon the occurrence of a Change of Control Triggering
Event, unless the Company has exercised its right to redeem this Security, the holder of this Security will have the right to require that the Company purchase all or a portion, in $1,000 increments (provided that any remaining principal
amount thereof shall be at least the minimum authorized denomination thereof), of this Security at a purchase price equal to 101% of the principal amount hereof plus accrued and unpaid interest, if any, to the date of purchase. Within 30 days
following the date upon which the Change of Control Triggering Event occurred, or at the Company’s option, prior to any Change of Control, but after the public announcement of the Change of Control, the Company shall send, by first class mail,
a notice to each Holder, with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer. 
 7. Denominations, Transfer, Exchange. The Securities are in registered form without coupons in the denominations of $2,000 or any integral multiple of $1,000 in excess thereof. The transfer of Securities may be registered
and Securities may be exchanged as provided in the Indenture. The Securities may be presented for exchange or for registration of transfer (duly endorsed or with the form of transfer endorsed thereon duly executed if so required by the Company or
the Security Registrar) at the office of the Security Registrar or at the office of any transfer agent designated by the Company for such purpose. No service charge will be made for any registration of transfer or exchange, but a Securityholder may
be required to pay any applicable taxes or other governmental charges. If the Securities are to be redeemed, the Company will not be required to: (i) issue, register the transfer of, or exchange any Security during a period beginning at the
opening of business 15 days before the day of mailing of a notice of redemption of less than all of the outstanding Securities of the same series and ending at the close of business on the day of such mailing; (ii) register the transfer of or
exchange any Security of any series or portions thereof selected for redemption, in whole or in part, except the unredeemed portion of any such Security being redeemed in part; nor (iii) register the transfer of or exchange a Security of any
series between the applicable record date and the next succeeding Interest Payment Date. 
 8. Persons Deemed Owners. The
registered Securityholder may be treated as its owner for all purposes. 
 9. Repayment to Holdco, Parent or the Company. Any funds or
Governmental Obligations deposited with any paying agent or the Trustee, or then held by Holdco, Parent or the Company, in trust for payment of principal of, premium, if any, or interest on the Securities of a particular series that are not applied
but remain unclaimed by the holders of such Securities for at least one year after the date upon which the principal of, premium, if any, or interest on such Securities shall have respectively become due and payable, shall be repaid to Holdco,
Parent or the Company, as applicable, or (if then held by Holdco, Parent or the Company) shall be discharged from such trust. After return to the Company, Parent or Holdco, Holders entitled to the money or securities must look to the Company, Parent
or Holdco, as applicable, for payment as unsecured general creditors. 
 10. Amendments, Supplements and Waivers. The
Indenture contains provisions permitting the Company, Parent, Holdco and the Trustee, with the consent of the holders of not less than a majority in aggregate principal amount of the Outstanding Securities to enter into supplemental indentures for
the purpose of adding, changing or eliminating any provisions to the 

  

 C-8 

 
Base Indenture or supplemental indenture or indentures or of modifying in any manner not covered elsewhere in the Base Indenture the rights of the holders of
the Securities of such series; provided, however, that no such supplemental indenture, without the consent of the holders of each Security then Outstanding and affected thereby, shall: (i) extend a fixed maturity of or any
installment of principal of any Securities of any series or reduce the principal amount thereof, or reduce the amount of principal of any original issue discount security that would be due and payable upon declaration of acceleration of the maturity
thereof; (ii) reduce the rate of or extend the time for payment of interest of any Security of any series; (iii) reduce the premium payable upon the redemption of any Security; (iv) make any Security payable in Currency other than
that stated in the Security; (v) impair the right to institute suit for the enforcement of any payment on or after the fixed maturity thereof (or in the case or redemption, on or after the redemption date); or (vi) reduce the percentage of
Securities, the holders of which are required to consent to any such supplemental indenture or indentures. The Base Indenture also contains provisions permitting the holders of not less than a majority in aggregate principal amount of the
Outstanding securities of each series affected thereby, on behalf of all of the holders of the securities of such series, to waive any past Default under the Base Indenture, and its consequences, except a Default in the payment of the principal of,
premium, if any, or interest on any security of such series or a Default in respect of a covenant or provision of the Base Indenture that cannot be modified or amended without the consent of the holder of each Outstanding security of such affected
series. Any such consent or waiver by the registered Securityholder shall be conclusive and binding upon such holder and upon all future holders and owners of this Security and of any Security issued in exchange for this Security or in place hereof
(whether by registration of transfer or otherwise), irrespective of whether or not any notation of such consent or waiver is made upon this Security. 
 11. Defaults and Remedies. If an Event of Default with respect to the securities of a series issued pursuant to the Base Indenture occurs and is continuing, the Trustee or the holders of at least 25%
in aggregate principal amount of the Securities of such series then Outstanding, by notice in writing to the Company, Parent and Holdco (and to the Trustee if notice is given by such holders), may declare the unpaid principal of, premium, if any,
and accrued interest, if any, due and payable immediately. Subject to the terms of the Indenture, if an Event of Default under the Indenture shall occur and be continuing, the Trustee will be under no obligation to exercise any of its rights or
powers under the Indenture at the request or direction of any of the holders, unless such holders have offered the Trustee indemnity satisfactory to it. Upon satisfaction of certain conditions set forth in the Indenture, the holders of a majority in
principal amount of the Outstanding securities of a series issued pursuant to the Base Indenture will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust
or power conferred on the Trustee, with respect to the securities of such series. 
 12. Trustee, Paying Agent and Security Registrar May
Hold Securities. The Trustee, subject to certain limitations imposed by the TIA, or any paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have
if it were not Trustee, paying agent or Security Registrar. 
 13. No Recourse Against Others. No recourse under or upon any
obligation, covenant or agreement of the Indenture, or of any Security, or for any claim based thereon or otherwise in 

  

 C-9 

 
respect hereof or thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of Holdco, Parent or the
Company or of any predecessor or successor corporation, either directly or through Holdco, Parent or the Company or any such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement
of any assessment or penalty or otherwise; it being expressly understood that the Indenture and the obligations issued hereunder and thereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or
shall be incurred by, the incorporators, shareholders, officers or directors as such, of Holdco, Parent or the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness authorized by the
Indenture, or under or by reason of the obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in
equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness authorized by the Indenture, or under or by
reason of the obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the acceptance of the Securities.

 14. Discharge of Indenture. The Indenture contains certain provisions pertaining to defeasance, which provisions shall
for all purposes have the same effect as if set forth herein. 
 15. Authentication. This Security shall not be valid until
the Trustee signs the certificate of authentication attached to the other side of this Security. 
 16. Guarantees. All payments by
the Company under the Indenture and this Security are jointly and severally, fully and unconditionally guaranteed to the holder of this Security by Holdco and Parent, as provided in the related Guarantee and the Indenture. 
 17. Additional Amounts. The Company, Parent and Holdco are obligated to pay Additional Amounts on this Security to the extent provided in Article
XIV of the Indenture. 
 18. Abbreviations. Customary abbreviations may be used in the name of a Securityholder or an
assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

19. Governing Law. The Base Indenture, the Third Supplemental Indenture, the Fifth Supplemental Indenture and this Security (and the
Guarantee hereon) shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said State. 
  

 C-10 

 ASSIGNMENT FORM 
  

 

	
	 To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to

	
	 
	(Insert assignee’s soc. sec. or tax I.D. no.)
	
	 
	
	 
	
	 
	
	 
	(Print or type assignee’s name, address and zip code)

			
	and irrevocably appoint	 	 
	agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.
	
	 

  

			
	Date:	 	  

  

			
	Your Signature:	 	  

	(Sign exactly as your name appears on the face of this Security)

  

			
	Signature Guarantee:	 	  

  

 C-11 

 OPTION OF HOLDER TO ELECT PURCHASE 
 If you want to elect to have this Security purchased by the Company pursuant to Section 1.3(3) of the Third Supplemental Indenture, check the box:

  ̈  1.3(3) Change of Control Triggering Event 
 If you want to elect to have only part of this Security purchased by the Company pursuant to Section 1.3(3) of the Third Supplemental
Indenture, state the amount: $            . 
  

			
	 Date:                     
	 	Your Signature:
		 	 (Sign exactly as your name appears
 on the other side
of the Security)

 Tax I.D. number 
  

			
	Signature Guarantee:	 	  

		 	(Signature must be guaranteed by a participant in a recognized signature guarantee medallion program)

  

 C-12 

 ANNEX D 
 FORM OF 6.550% SENIOR NOTES 
 [Insert the Private Placement Legend and/or the Global Security
legend, as applicable] 
 6.550% SENIOR NOTES DUE 2037 
  

			
	 No. [    ]
	  	$[            ]
	 CUSIP No. [            ]
	  	

 COVIDIEN INTERNATIONAL FINANCE S.A. 
 promises to pay to Cede & Co. or registered assigns, the principal sum of [            ] Dollars on October 15, 2037. 
 Interest Payment Dates: April 15 and October 15 
 Record Dates:
April 1 and October 1] 
 Each holder of this Security (as defined below), by accepting the same, agrees to and shall be bound by
the provisions hereof and of the Indenture described herein, and authorizes and directs the Trustee described herein on such holder’s behalf to be bound by such provisions. Each holder of this Security hereby waives all notice of the acceptance
of the provisions contained herein and in the Indenture and waives reliance by such holder upon said provisions. 
 This Security shall not
be entitled to any benefit under the Indenture, or be valid or become obligatory for any purpose, until the Certificate of Authentication hereon shall have been signed by or on behalf of the Trustee. The provisions of this Security are continued on
the reverse side hereof, and such continued provisions shall for all purposes have the same effect as though fully set forth at this place. 
 IN WITNESS
WHEREOF, the Company has caused this instrument to be signed in accordance with Section 2.04 of the Indenture. 
 Date:
[            ] 
  

	
	COVIDIEN INTERNATIONAL FINANCE S.A.
	
	  

	Name:
	Title:
	
	[If second signature is applicable:]
	
	  

	Name:

  

 D-1 

	
	Title:

  

 D-2 

 CERTIFICATE OF AUTHENTICATION 
 This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 
  

			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee
		
	By:	 	  

		 	Authorized Signatory
		
	By:	 	  

		 	Authorized Signatory
		
	Dated:	 	[            ]

  

 D-3 

 GUARANTEE 
 For value received, each of Covidien plc and Covidien Ltd. hereby jointly and severally, absolutely, unconditionally and irrevocably guarantees to the holder of this Security the payment of principal of, premium, if
any, and interest on, the Security upon which this Guarantee is set forth in the amounts and at the time when due and payable whether by declaration thereof, or otherwise, and interest on the overdue principal and interest, if any, of such Security,
if lawful, to the holder of such Security and the Trustee on behalf of the Holders, all in accordance with and subject to the terms and limitations of such Security and Article XV of the Indenture. This Guarantee will not become effective until the
Trustee or Authenticating Agent duly executes the certificate of authentication on this Security. This Guarantee shall be governed by and construed in accordance with the laws of the State of New York, without regard to conflict of law principles
thereof. 
 Dated: [            ] 
  

			
	COVIDIEN LTD.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	 PRESENT when the COMMON SEAL of
 COVIDIEN PLC
was affixed hereto

	
	  

	Director
	
	  

	Secretary

  

 D-4 

 Covidien International Finance S.A. 
 6.550% Senior Notes due 2037 
 This security is one of a duly authorized series of debt
securities of Covidien International Finance S.A., a Luxembourg company (the “Company”), issued or to be issued in one or more series under and pursuant to an Indenture for the Company’s unsubordinated debt securities, dated as of
October 22, 2007 (the “Base Indenture”), duly executed and delivered by and among the Company, Covidien Ltd. (“Parent”) and Deutsche Bank Trust Company Americas (the “Trustee”), as supplemented by the Fourth
Supplemental Indenture, dated as of October 22, 2007 (the “Fourth Supplemental Indenture”), by and among the Company, Parent and the Trustee, and the Fifth Supplemental Indenture, dated as of June 4, 2009 (the “Fifth
Supplemental Indenture”), by and among the Company, Parent, Covidien plc (“Holdco”) and the Trustee. The Base Indenture as supplemented and amended by the Fourth Supplemental Indenture and the Fifth Supplemental Indenture is referred
to herein as the “Indenture.” By the terms of the Base Indenture, the debt securities issuable thereunder are issuable in series that may vary as to amount, date of maturity, rate of interest and in other respects as provided in the Base
Indenture. This security is one of the series designated on the face hereof (individually, a “Security,” and collectively, the “Securities”), and reference is hereby made to the Indenture for a description of the rights,
limitations of rights, obligations, duties and immunities of the Trustee, the Company, Parent, Holdco and the holders of the Securities (the “Securityholders”). Capitalized terms used herein and not otherwise defined shall have the
meanings given them in the Base Indenture or the Fourth Supplemental Indenture, as applicable, in each case as amended by the Fifth Supplemental Indenture. 
 1. Interest. The Company promises to pay interest on the principal amount of this Security at an annual rate of 6.550%. The Company will pay interest semi-annually on April 15 and October 15 of
each year (each such day, an “Interest Payment Date”). If any Interest Payment Date, redemption date or maturity date of this Security is not a Business Day, then payment of interest or principal (and premium, if any) shall be made on the
next succeeding Business Day with the same force and effect as if made on the date such payment was due, and no interest shall accrue for the period after such date to the date of such payment on the next succeeding Business Day. Interest on the
Securities will accrue from the most recent date to which interest has been paid or duly provided for or, if no interest has been paid, from the date of issuance; provided that, if there is no existing Default in the payment of interest, and if this
Security is authenticated between a regular record date referred to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date; and provided, further, that the first
Interest Payment Date shall be April 15, 2008. Interest will be calculated on the basis of a 360-day year of twelve 30-day months. In certain circumstances, liquidated damages may be payable as provided in Section 6.01 of the Indenture.
Any such liquidated damages shall be payable in the same manner and on the same dates as the stated interest payable on this Security. 
 The
Holder of this Security is entitled to the benefits of the Exchange and Registration Rights Agreement. Pursuant to the Exchange and Registration Rights Agreement, the Company has agreed (i) to file the Exchange Registration Statement (as
defined in the Exchange and 

  

 D-5 

 
Registration Rights Agreement) as soon as practicable, but no later than 210 days after the Closing Date (as defined in the Exchange and Registration Rights
Agreement), (ii) to use its commercially reasonable efforts to cause such Exchange Registration Statement to become effective under the Securities Act as soon as practicable, but no later than 300 days after the Closing Date, and (iii) to
use its commercially reasonable efforts to commence and complete the Exchange Offer (as defined in the Exchange and Registration Rights Agreement) promptly, but no later than 45 days after such registration statement has become effective, hold the
Exchange Offer open for at least 30 days and exchange Exchange Securities (as defined in the Exchange and Registration Rights Agreement) for all Registrable Securities (as defined in the Exchange and Registration Rights Agreement) that have been
properly tendered and not withdrawn on or prior to the expiration of the Exchange Offer. If (i) on or prior to the time the Exchange Offer is completed existing SEC interpretations are changed such that debt securities or the related guarantee
received by holders other than Restricted Holders (as defined in the Exchange and Registration Rights Agreement) in the Exchange Offer for Registrable Securities (as defined in the Exchange and Registration Rights Agreement) are not or would not be,
upon receipt, transferable by each such holder without restriction under the Securities Act, (ii) the Exchange Offer is not completed within 345 days after the Closing Date or (iii) the Exchange Offer is not available to any Holder, then,
in each case, the Company is required to (a) as soon as practicable but no later than 60 days after the time such obligation to file arises, file a Shelf Registration Statement (as defined in the Exchange and Registration Rights Agreement) and
(b) use its commercially reasonable best efforts to cause the Shelf Registration Statement to become or be declared effective within 120 days after such Shelf Registration Statement is filed and to keep such Shelf Registration Statement
continuously effective until the earlier of two years after the date as of which the Shelf Registration Statement became or was declared effective or such time as there are no longer any Registrable Securities outstanding. If (i) the Company
fails to file the Exchange Registration Statement or the Shelf Registration Statement on or before the date specified for such filing, (ii) any of the Exchange Registration Statement or the Shelf Registration Statement is not declared effective
by the date specified for such effectiveness, (iii) the Company fails to complete the Exchange Offer within 45 after the effectiveness target date with respect to the Exchange Registration Statement, (iv) any of the Exchange Registration
Statement or the Shelf Registration Statement is declared effective but thereafter is withdrawn or ceases to be effective due to a stop order issued pursuant to the Securities Act suspending the effectiveness of such registration statement without
being succeeded by an additional registration statement filed and declared effective or (v) the Company requires Holders to refrain from disposing of their Registrable Securities under certain circumstances described in the Exchange and
Registration Rights Agreement and that suspension period exceeds 45 days in any one instance or 90 days in the aggregate during any consecutive 12 month period (each such event referred to in clauses (i) through (v), a “Registration
Default” and each period during which a Registration Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages for such Registration Default, subject to certain exceptions, special interest
(“Special Interest”) shall accrue at a per annum rate of 0.25% for the first 90 days of the Registration Default Period and at a per annum rate of 0.50% thereafter for the remaining portion of the Registration Default Period. 

2. Method of Payment. The Company will pay interest on the Securities (except defaulted interest), if any, to the persons in whose
name such Securities are registered at the close of business on the regular record date referred to on the facing page of this Security for 

  

 D-6 

 
such interest installment. In the event that the Securities or a portion thereof are called for redemption and the Redemption Date is subsequent to a regular
record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Securities will be paid upon presentation and surrender of such Securities as provided in the Indenture. The principal of and the
interest on the Securities shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose in accordance with
the Indenture. 
 3. Paying Agent and Registrar. Initially, Deutsche Bank Trust Company Americas, the Trustee, will act as
paying agent and Security Registrar. The Company may change or appoint any paying agent or Security Registrar without notice to any Securityholder. Holdco, Parent, the Company or any of their Subsidiaries may act in any such capacity. 
 4. Indenture. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the
Trust Indenture Act of 1939 (“TIA”) as in effect on the date the Indenture is qualified. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and TIA for a statement of such terms. The Securities
are unsecured general obligations of the Company and constitute the series designated on the face hereof as the “6.550% Senior Notes due 2037”, initially limited to $850,000,000 in aggregate principal amount. The Company will furnish to
any Securityholder upon written request and without charge a copy of the Base Indenture, the Fourth Supplemental Indenture and the Fifth Supplemental Indenture. Requests may be made to: Covidien International Finance S.A., 4th Floor, 3b bd Prince
Henri,L-1724 Luxembourg, Attention: The Managing Directors. 
 5. Optional Redemption. The Securities will be subject to
redemption at the option of the Company on any date prior to the maturity date, in whole or from time to time in part, in $1,000 increments (provided that any remaining principal amount thereof shall be at least the minimum authorized
denomination thereof), on written notice given to the Securityholders thereof not less than 30 days nor more than 90 days prior to the date fixed for redemption in such notice (the “Redemption Date”), at a redemption price equal to the
greater of (i) 100% of the principal amount of such Securities to be redeemed and (ii) as determined by the Quotation Agent and delivered to the Trustee, the sum of the present values of the remaining scheduled payments of principal and
interest thereon due on any date after the Redemption Date (excluding the portion of interest that will be accrued and unpaid to and including the Redemption Date) discounted from their scheduled date of payment to the Redemption Date (assuming a
360-day year consisting of twelve 30-day months) at the Adjusted Redemption Treasury Rate plus 30 basis points (such greater amount is referred to herein as the “Redemption Price”), plus, in either the case of clause (i) or clause
(ii), accrued and unpaid interest and Special Interest, if any, thereon to the Redemption Date. This Security is also subject to redemption to the extent provided in Article XIV of the Indenture. 
 If the giving of the notice of redemption is completed as provided in the Indenture, interest on such Securities or portions of Securities shall cease to
accrue on and after the Redemption Date, unless the Company shall default in the payment of such Redemption Price and accrued interest with respect to any such Security or portion thereof. 
  

 D-7 

 The Company shall not be required to make mandatory redemption or sinking fund payments with respect to
the Securities. 
 6. Change of Control Triggering Event. Upon the occurrence of a Change of Control Triggering Event, unless the
Company has exercised its right to redeem this Security, the holder of this Security will have the right to require that the Company purchase all or a portion, in $1,000 increments (provided that any remaining principal amount thereof shall
be at least the minimum authorized denomination thereof), of this Security at a purchase price equal to 101% of the principal amount hereof plus accrued and unpaid interest, if any, to the date of purchase. Within 30 days following the date upon
which the Change of Control Triggering Event occurred, or at the Company’s option, prior to any Change of Control, but after the public announcement of the Change of Control, the Company shall send, by first class mail, a notice to each Holder,
with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer. 
 7. Denominations, Transfer,
Exchange. The Securities are in registered form without coupons in the denominations of $2,000 or any integral multiple of $1,000 in excess thereof. The transfer of Securities may be registered and Securities may be exchanged as provided in
the Indenture. The Securities may be presented for exchange or for registration of transfer (duly endorsed or with the form of transfer endorsed thereon duly executed if so required by the Company or the Security Registrar) at the office of the
Security Registrar or at the office of any transfer agent designated by the Company for such purpose. No service charge will be made for any registration of transfer or exchange, but a Securityholder may be required to pay any applicable taxes or
other governmental charges. If the Securities are to be redeemed, the Company will not be required to: (i) issue, register the transfer of, or exchange any Security during a period beginning at the opening of business 15 days before the day of
mailing of a notice of redemption of less than all of the outstanding Securities of the same series and ending at the close of business on the day of such mailing; (ii) register the transfer of or exchange any Security of any series or portions
thereof selected for redemption, in whole or in part, except the unredeemed portion of any such Security being redeemed in part; nor (iii) register the transfer of or exchange a Security of any series between the applicable record date and the
next succeeding Interest Payment Date. 
 8. Persons Deemed Owners. The registered Securityholder may be treated as its
owner for all purposes. 
 9. Repayment to Holdco, Parent or the Company. Any funds or Governmental Obligations deposited with any
paying agent or the Trustee, or then held by Holdco, Parent or the Company, in trust for payment of principal of, premium, if any, or interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such
Securities for at least one year after the date upon which the principal of, premium, if any, or interest on such Securities shall have respectively become due and payable, shall be repaid to Holdco, Parent or the Company, as applicable, or (if then
held by Holdco, Parent or the Company) shall be discharged from such trust. After return to the Company, Parent or Holdco, Holders entitled to the money or securities must look to the Company, Parent or Holdco, as applicable, for payment as
unsecured general creditors. 
  

 D-8 

 10. Amendments, Supplements and Waivers. The Indenture contains provisions permitting
the Company, Parent, Holdco and the Trustee, with the consent of the holders of not less than a majority in aggregate principal amount of the Outstanding Securities to enter into supplemental indentures for the purpose of adding, changing or
eliminating any provisions to the Base Indenture or supplemental indenture or indentures or of modifying in any manner not covered elsewhere in the Base Indenture the rights of the holders of the Securities of such series; provided,
however, that no such supplemental indenture, without the consent of the holders of each Security then Outstanding and affected thereby, shall: (i) extend a fixed maturity of or any installment of principal of any Securities of any
series or reduce the principal amount thereof, or reduce the amount of principal of any original issue discount security that would be due and payable upon declaration of acceleration of the maturity thereof; (ii) reduce the rate of or extend
the time for payment of interest of any Security of any series; (iii) reduce the premium payable upon the redemption of any Security; (iv) make any Security payable in Currency other than that stated in the Security; (v) impair the
right to institute suit for the enforcement of any payment on or after the fixed maturity thereof (or in the case or redemption, on or after the redemption date); or (vi) reduce the percentage of Securities, the holders of which are required to
consent to any such supplemental indenture or indentures. The Base Indenture also contains provisions permitting the holders of not less than a majority in aggregate principal amount of the Outstanding securities of each series affected thereby, on
behalf of all of the holders of the securities of such series, to waive any past Default under the Base Indenture, and its consequences, except a Default in the payment of the principal of, premium, if any, or interest on any security of such series
or a Default in respect of a covenant or provision of the Base Indenture that cannot be modified or amended without the consent of the holder of each Outstanding security of such affected series. Any such consent or waiver by the registered
Securityholder shall be conclusive and binding upon such holder and upon all future holders and owners of this Security and of any Security issued in exchange for this Security or in place hereof (whether by registration of transfer or otherwise),
irrespective of whether or not any notation of such consent or waiver is made upon this Security. 
 11. Defaults and
Remedies. If an Event of Default with respect to the securities of a series issued pursuant to the Base Indenture occurs and is continuing, the Trustee or the holders of at least 25% in aggregate principal amount of the Securities of such
series then Outstanding, by notice in writing to the Company, Parent and Holdco (and to the Trustee if notice is given by such holders), may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately.
Subject to the terms of the Indenture, if an Event of Default under the Indenture shall occur and be continuing, the Trustee will be under no obligation to exercise any of its rights or powers under the Indenture at the request or direction of any
of the holders, unless such holders have offered the Trustee indemnity satisfactory to it. Upon satisfaction of certain conditions set forth in the Indenture, the holders of a majority in principal amount of the Outstanding securities of a series
issued pursuant to the Base Indenture will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the
securities of such series. 
 12. Trustee, Paying Agent and Security Registrar May Hold Securities. The Trustee, subject to certain
limitations imposed by the TIA, or any paying agent or Security Registrar, in 

  

 D-9 

 
its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not Trustee, paying agent
or Security Registrar. 
 13. No Recourse Against Others. No recourse under or upon any obligation, covenant or agreement of
the Indenture, or of any Security, or for any claim based thereon or otherwise in respect hereof or thereof, shall be had against any incorporator, stockholder, officer or director, past, present or future as such, of Holdco, Parent or the Company
or of any predecessor or successor corporation, either directly or through Holdco, Parent or the Company or any such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any
assessment or penalty or otherwise; it being expressly understood that the Indenture and the obligations issued hereunder and thereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall
be incurred by, the incorporators, shareholders, officers or directors as such, of Holdco, Parent or the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness authorized by the Indenture,
or under or by reason of the obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity or by
constitution or statute, of, and any and all such rights and claims against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness authorized by the Indenture, or under or by reason of the
obligations, covenants or agreements contained in the Indenture or in the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the acceptance of the Securities. 
 14. Discharge of Indenture. The Indenture contains certain provisions pertaining to defeasance, which provisions shall for all purposes
have the same effect as if set forth herein. 
 15. Authentication. This Security shall not be valid until the Trustee signs
the certificate of authentication attached to the other side of this Security. 
 16. Guarantees. All payments by the Company under
the Indenture and this Security are jointly and severally, fully and unconditionally guaranteed to the holder of this Security by Holdco and Parent, as provided in the related Guarantee and the Indenture. 
 17. Additional Amounts. The Company, Parent and Holdco are obligated to pay Additional Amounts on this Security to the extent provided in Article
XIV of the Indenture. 
 18. Abbreviations. Customary abbreviations may be used in the name of a Securityholder or an
assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

19. Governing Law. The Base Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture and this Security (and the
Guarantee hereon) shall be deemed to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said State. 
  

 D-10 

 ASSIGNMENT FORM 
 To assign this Security, fill in the form below: (I) or (we) assign and transfer this Security to 
  

	
	  

	 (Insert assignee’s soc. sec. or tax I.D. no.)

	
	  

	
	  

	
	  

	
	  

	(Print or type assignee’s name, address and zip code)

			
	and irrevocably appoint	 	  

	agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.
	
	  

  

			
	 Date:
	 	  

  

			
	 Your Signature:
	 	  

	(Sign exactly as your name appears on the face of this Security)

  

			
	 Signature Guarantee:
	 	  

  

 D-11 

 OPTION OF HOLDER TO ELECT PURCHASE 
 If you want to elect to have this Security purchased by the Company pursuant to Section 1.3(3) of the Fourth Supplemental Indenture, check the box:

  ̈  1.3(3) Change of Control Triggering Event 
 If you want to elect to have only part of this Security purchased by the Company pursuant to Section 1.3(3) of the Fourth Supplemental
Indenture, state the amount: $            . 
  

			
	 Date:                     
	 	Your Signature:
		 	(Sign exactly as your name appears
		 	on the other side of the Security)

 Tax I.D. number 
  

			
	 Signature Guarantee:
	 	  

		 	(Signature must be guaranteed by a participant in a recognized signature guarantee medallion program)

  

 D-12Covidien 2007 Stock and Incentive Plan (as amended and restated)

 Exhibit 10.1 
 COVIDIEN 2007 STOCK AND INCENTIVE PLAN 
 AS AMENDED AND RESTATED ON NOVEMBER 21, 2008 AND JUNE 4,
2009 AND 
 AS ASSUMED BY COVIDIEN PUBLIC LIMITED COMPANY ON JUNE 4, 2009 
 ARTICLE I 
 PURPOSE 
 1.1 Purpose. The purposes of this Covidien 2007 Stock and Incentive Plan as amended and restated and as assumed by Covidien public limited company
(the “Plan”) are to promote the interests of Covidien public limited company (and any successor thereto) by (i) aiding in the recruitment and retention of Directors and Employees, (ii) providing incentives to Directors and
Employees by means of performance-related incentives to achieve short-term and long-term performance goals, (iii) providing Directors and Employees with an opportunity to participate in the growth and financial success of the Company, and
(iv) promoting the growth and success of the Company’s business by aligning the financial interests of Directors and Employees with that of the other shareholders of the Company. Toward these objectives, the Plan provides for the grant of
Stock Options, Stock Appreciation Rights, Annual Performance Bonuses, Long-Term Performance Awards and Other Stock-Based Awards. 
 1.2
Effective Date; Shareholder Approval. The Plan was amended and restated, effective as of November 21, 2008, and such amendment and restatement was approved by the shareholders of Covidien Ltd. at its 2009 annual general meeting held on
March 18, 2009. The Plan was amended and restated, effective as of June 4, 2009, to reflect its assumption by Covidien public limited company. 
 ARTICLE II 
 DEFINITIONS 
 For purposes of the Plan, the following terms have the following meanings, unless another definition is clearly indicated by particular usage and
context: 
 “ Acquired Company ” means any business, corporation or other entity acquired by the
Company or any Subsidiary. 
 “ Acquired Grantee ” means the grantee of a stock-based award of an Acquired
Company and may include a current or former Director of an Acquired Company. 
 “ Annual Performance Bonus ”
means an Award of cash or Shares granted under Section 4.4 of the Plan that is paid solely on account of the attainment of a specified performance target in relation to one or more Performance Measures. 
 “ Award ” means any form of incentive or performance award granted under the Plan, whether singly or in combination, to a
Participant by the Committee pursuant to any terms and conditions that the Committee may establish and set forth in the applicable Award Certificate. Awards granted under the Plan may consist of: 
  

	 	(a)	“ Stock Options ” awarded pursuant to Section 4.3; 

  

	 	(b)	“ Stock Appreciation Rights ” awarded pursuant to Section 4.3; 

  

	 	(c)	“ Annual Performance Bonuses ” awarded pursuant to Section 4.4; 

  

	 	(d)	“ Long-Term Performance Awards ” awarded pursuant to Section 4.5; 

  

	 	(e)	“ Other Stock-Based Awards ” awarded pursuant to Section 4.6; 

  

	 	(f)	“ Director Awards ” awarded pursuant to Section 4.7; and 

  

	 	(g)	“ Substitute Awards ”awarded pursuant to Section 4.8. 

 “ Award Certificate ” means the document issued, either in writing or an
electronic medium, by the Committee or its designee to a Participant evidencing the grant of an Award and which contains, in the same or accompanying document, the terms and conditions applicable to such Award. 
 “ Board ” means the Board of Directors of the Company. 
 “ Cause ” means an Employee’s or Director’s (i) substantial failure or refusal to perform duties and
responsibilities of his or her job as required by the Company or Subsidiary, (ii) violation of any fiduciary duty owed to the Company or Subsidiary, (iii) conviction of a felony or misdemeanor, (iv) dishonesty, (v) theft,
(vi) violation of Company or Subsidiary rules or policy, or (vii) other egregious conduct, that has or could have a serious and detrimental impact on the Company or Subsidiary and its employees. The Committee (or the Nominating Committee
solely with respect to Director Awards), in its sole and absolute discretion, shall determine Cause. 
 “ Change in
Control ” means the first to occur of any of the following events: 
 (a) any “person” (as defined in
Section 13(d) and 14(d) of the Exchange Act, excluding for this purpose, (i) the Company or any Subsidiary or (ii) any employee benefit plan of the Company or any Subsidiary (or any person or entity organized, appointed or established
by the Company for or pursuant to the terms of any such plan that acquires beneficial ownership of voting securities of the Company), is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act) directly or
indirectly of securities of the Company representing more than 30 percent of the combined voting power of the Company’s then outstanding securities; provided, however, that no Change in Control will be deemed to have occurred as a result of a
change in ownership percentage resulting solely from an acquisition of securities by the Company; or 
 (b) persons who, as
of the Effective Date constitute the Board (the “Incumbent Directors”) cease for any reason (including without limitation, as a result of a tender offer, proxy contest, merger or similar transaction) to constitute at least a majority
thereof, provided that any person becoming a Director of the Company subsequent to the Effective Date shall be considered an Incumbent Director if such person’s election or nomination for election was approved by a vote of at least 50 percent
of the Incumbent Directors; but provided further, that any such person whose initial assumption of office is in connection with an actual or threatened proxy contest relating to the election of members of the Board or other actual or threatened
solicitation of proxies or consents by or on behalf of a “person” (as defined in Section 13(d) and 14(d) of the Exchange Act) other than the Board, including by reason of agreement intended to avoid or settle any such actual or
threatened contest or solicitation, shall not be considered an Incumbent Director; or 
 (c) consummation of a
reorganization, merger or consolidation or sale or other disposition of at least 80 percent of the assets of the Company (a “Business Combination”), in each case, unless, following such Business Combination, all or substantially all of the
individuals and entities who were the beneficial owners of outstanding voting securities of the Company immediately prior to such Business Combination beneficially own directly or indirectly more than 50 percent of the combined voting power of the
then outstanding voting securities entitled to vote generally in the election of directors, of the company resulting from such Business Combination (including, without limitation, a company which, as a result of such transaction, owns the Company or
all or substantially all of the Company’s assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the outstanding voting securities
of the Company; or 
 (d) approval by the shareholders of the Company of a complete liquidation or dissolution of the
Company. 
 “ Change in Control Termination ” means a Participant’s involuntary termination of
employment that occurs during the twelve (12) month period immediately following a Change in Control. For this purpose, a Participant’s involuntary termination of employment includes only the following: 
  

 - 2 - 

	 	(a)	termination of the Participant’s employment by the Company for any reason other than for Cause, Disability or death; 

  

	 	(b)	termination of the Participant’s employment by the Participant after one of the following events, provided that the Participant’s termination of employment occurs within
sixty (60) days after the occurrence of any such event: 

  

	 	(i)	the Company (1) assigns or causes to be assigned to the Participant duties inconsistent in any material respect with his or her position as in effect immediately prior to the
Change in Control; (2) makes or causes to be made any material adverse change in the Participant’s position (including titles and reporting relationships and level), authority, duties or responsibilities; or (3) takes or causes to be
taken any other action which, in the reasonable judgment of the Participant, would cause him or her to violate his or her ethical or professional obligations (after written notice of such judgment has been provided by the Participant to the Company
and the Company has been given a 15-day period within which to cure such action), or which results in a significant diminution in such position, authority, duties or responsibilities; or 

  

	 	(ii)	the Company, without the Participant’s consent, (1) requires the Participant to relocate to a principal place of employment more than fifty (50) miles from his or her
existing place of employment; or (2) reduces the Participant’s base salary, annual bonus, or retirement, welfare, share incentive, perquisite (if any) and other benefits taken as a whole. 

 “ Code ” means the United States Internal Revenue Code of 1986, as amended. 
 “ Committee ” means the Compensation and Human Resources Committee of the Board or any successor committee or other
committee to which the Compensation and Human Resources Committee delegates its authority under this Plan. The Compensation and Human Resources Committee is comprised solely of nonemployee directors within the meaning of Rule 16b-3(b)(3) of the
Exchange Act and two or more persons who are outside directors within the meaning of Section 162(m)(4)(C)(i) of the Code and the applicable regulations. 
 “ Company ” means Covidien public limited company, a company incorporated in Ireland under registered number 466385, or
any successor thereto. 
 “ Deferred Stock Unit ” means a Unit granted under Section 4.6 or 4.7 to
acquire Shares upon Termination of Directorship or Termination of Employment, subject to any restrictions that the Committee, in its discretion, may determine. 
 “ Director ” means a member of the Board who is a “non-employee director” within the meaning of Rule
16b-3(b)(3) under the Exchange Act. 
 “ Disabled ” or “ Disability ” means that the
Employee has a permanent and total incapacity from engaging in any employment for the Company or Subsidiary for physical or mental reasons. A “Disability” shall be deemed to exist if the Employee is designated with an inactive employment
status at the end of a disability or medical leave or if the Employee meets the requirements for disability benefits under (i) the Company’s or Subsidiary’s long-term disability plan or (ii) the Social Security law then in
effect, for Employees who are on the payroll of any United States Subsidiary. 
 “ Dividend Equivalent ”
means an amount equal to the cash dividend or the fair market value of the share dividend that would be paid on each Share underlying an Award if the Share were duly issued and outstanding on the date on which the dividend is payable. 
 “ Effective Date ” means June 4, 2009, unless otherwise provided herein. 
 “ Employee ” means any individual who performs services as an officer or employee of the Company or a Subsidiary.

  

 - 3 - 

 “ Exchange Act ” means the United States Securities Exchange Act of
1934, as amended. 
 “ Exercise Price ” means the price of a Share, as fixed by the Committee, which may be
purchased under a Stock Option or with respect to which the amount of any payment pursuant to a Stock Appreciation Right is determined. 
 “ Fair Market Value ” of a Share means the closing sales price on the New York Stock Exchange of a Share on the trading day of the grant or on the date as of which the determination of Fair Market
Value is being made or, if no sale is reported for such day, on the next preceding day on which a sale of Shares is reported. Notwithstanding anything to the contrary herein, the Fair Market Value of a Share will in no event be determined to be less
than par value. 
 “ GAAP ” means United States generally accepted accounting principles. 
 “ Incentive Stock Option ” means a Stock Option granted under Section 4.3 of the Plan that meets the requirements of
Section 422 of the Code and any related regulations and is designated in the Award Certificate to be an Incentive Stock Option. 
 “ Key Employee ” means an Employee who is a “covered employee” within the meaning of Section 162(m)(3) of the Code or who is reasonably expected to be a “covered employee” at the time an Award
becomes payable. 
 “ Long-Term Performance Award ” means an Award granted under Section 4.5 of the Plan
that is paid solely on account of the attainment of a specified performance target in relation to one or more Performance Measures or other performance criteria as selected in the sole discretion of the Committee. 
 “ Nominating Committee ” means the Nominating and Governance Committee the Board. 
 “ Non-Employee Director ” means any member of the Board, elected or appointed, who is not otherwise an Employee of the
Company or a Subsidiary. An individual who is elected to the Board at an annual meeting of the shareholders of the Company will be deemed to be a member of the Board as of the date of such meeting. 
 “ Nonqualified Stock Option ” means any Stock Option granted under Section 4.3 of the Plan that is not an Incentive
Stock Option. 
 “ Normal Retirement ” means Termination of Employment on or after a Participant has attained
age 60, provided that the sum of the Participant’s age and years of service with the Company or a Subsidiary is 70 or higher. 
 “ Ordinary Shares ” means the ordinary shares of the Company, $0.20 (U.S.) par value, and such other securities or property as may become subject to Awards pursuant to an adjustment made under Section 5.3 of the Plan.

 “ Other Stock-Based Award ” means an Award granted under Section 4.6 of the Plan and denominated in
Shares. 
 “ Participant ” means a Director, Employee or Acquired Grantee who has been granted an Award under
the Plan. 
 “ Performance Cycle ” means, with respect to any Award that vests based on Performance Measures,
the period of 12 months or longer over which the level of performance will be assessed. The first Performance Cycle under the Plan will begin on such date as is set by the Committee, in its sole discretion. 
 “ Performance Measure ” means, with respect to any Annual Performance Bonus or Long-Term Performance Award, the business criteria
selected by the Committee to measure the level of performance of the Company during a Performance Cycle. The Committee may select as the Performance Measure any operating and maintenance expense targets or financial goals as interpreted by the
Committee, either individually, alternatively or in any combination, applied to either the Company as a whole or to a business unit or Subsidiary, either individually, alternatively or in any combination, and measured during the Performance Cycle
including, but not limited to the following criteria: (a) cash flow, (b) earnings per share, (c) earnings before interest, taxes and amortization, (d) return on equity, (e) total shareholder return, (f) share price
performance, (g) return on capital, (h) return on assets or net assets, (i) revenue, (j) income or net income, (k)

  

 - 4 - 

 
operating income or net operating income, (l) operating profit or net operating profit, (m) operating margin or profit margin, (n) return on
operating revenue, (o) return on invested capital, (p) market segment share, (q) product release schedules, (r) new product innovation, (s) product cost reduction through advanced technology, (t) brand
recognition/acceptance, (u) product ship targets, or (v) customer satisfaction. 
 “ Performance Unit
” means a Long-Term Performance Award denominated in Units. 
 “ Plan ” means this Covidien 2007
Stock and Incentive Plan as amended and restated effective as of June 4, 2009 and as assumed by Covidien public limited company on June 4, 2009, as it may be amended from time to time. 
 “ Premium-Priced Stock Option ” means a Stock Option the Exercise Price of which is fixed by the Committee at a price
that exceeds the Fair Market Value of a Share on the date of grant. 
 “ Reporting Person ” means a Director
or an Employee who is subject to the reporting requirements of Section 16(a) of the Exchange Act. 
 “ Restricted
Stock ” means Shares issued pursuant to Section 4.6 that are subject to any restrictions that the Committee, in its discretion, may impose. 
 “ Restricted Unit ” means a Unit granted under Section 4.5 or Section 4.6 to acquire Shares or an equivalent amount in cash, which Unit is subject to any restrictions that the Committee, in
its discretion, may impose. 
 “ Securities Act ” means the United States Securities Act of 1933, as amended.

 “ Share ” means an Ordinary Share of the Company, and “Shares” shall be construed
accordingly. 
 “ Stock Appreciation Right ” means a right granted under Section 4.3 of the Plan of an
amount in cash or Shares equal to any difference between the Fair Market Value of the Shares as of the date on which the right is exercised and the Exercise Price. 
 “ Stock Option ” means a right granted under Section 4.3 of the Plan to purchase from the Company a stated number of
Shares at a specified price. Stock Options awarded under the Plan may be in the form of Incentive Stock Options or Nonqualified Stock Options. 
 “ Subsidiary ” means (i) a subsidiary company (wherever incorporated) of the Company, as defined by Section 155 of the Companies Act 1963 of Ireland; (ii) any separately organized
business unit, whether or not incorporated, of the Company; (iii) any employer that is required to be aggregated with the Company pursuant to Code Section 414 and the regulations promulgated thereunder; and (iv) any service recipient
or employer that is within a controlled group of corporations as defined in Code Sections 1563(a)(1), (2) and (3) where the phrase “at least 50%” is substituted in each place “at least 80%” appears and any service
recipient or employer within trades or businesses under common control as defined in Code Section 414(c) and Treas. Reg. § 1.414(c)-2 where the phrase “at least 50%” is substituted in each place “at least 80%” appears,
provided, however, that when the relevant determination is to be based upon legitimate business criteria (as described in Treas. Reg. § 1.409A-1(b)(5)(iii)(E) and § 1.409A-1(h)(3)), the phrase “at least 20%” shall be substituted
in each place “at least 80%” appears as described above with respect to both a controlled group of corporations and trades or business under common control. 
 “ Target Amount ” means the amount of Performance Units that will be paid if the Performance Measure is fully
(100%) attained, as determined in the sole discretion of the Committee. 
 “ Target Vesting Percentage ”
means the percentage of performance-based Restricted Units or Shares of Restricted Stock that will vest if the Performance Measure is fully (100%) attained, as determined in the sole discretion of by the Committee. 
 “ Termination of Directorship ” means the date of cessation of a Director’s membership on the Board for any reason,
with or without Cause, as determined in the sole discretion of the Nominating Committee, provided however that if the Director is a member of the Nominating Committee, such determination shall be made by the 

  

 - 5 - 

 
full Board (excluding such Director). 
 “ Termination of Employment ” means the date of cessation of an Employee’s employment relationship with the Company or a Subsidiary for any reason, with or without Cause, as determined in the sole discretion of the
Company. 
 “ Unit ” means, for purposes of Performance Units, the potential right to an Award equal to a
specified amount denominated in such form as is deemed appropriate in the discretion of the Committee and, for purposes of Restricted Units or Deferred Stock Units, the potential right to acquire one Share. 
 ARTICLE III 
 ADMINISTRATION 

 3.1 Committee. The Plan will be administered by the Committee, except as otherwise provided in Section 4.7. 
 3.2 Authority of the Committee. The Committee or, to the extent required by applicable law, the Board will have the authority, in its sole and
absolute discretion and subject to the terms of the Plan, to: 
 (a) Interpret and administer the Plan and any instrument or
agreement relating to the Plan; 
 (b) Prescribe the rules and regulations that it deems necessary for the proper operation
and administration of the Plan, and amend or rescind any existing rules or regulations relating to the Plan; 
 (c) Select
Employees to receive Awards under the Plan; 
 (d) Determine the form of an Award, the number of Shares subject to each
Award, all the terms and conditions of an Award, including, without limitation, the conditions on exercise or vesting, the designation of Stock Options as Incentive Stock Options or Nonqualified Stock Options, and the circumstances under which an
Award may be settled in cash or Shares or may be cancelled, forfeited or suspended, and the terms of each Award Certificate; 
 (e) Determine whether Awards will be granted singly, in combination or in tandem; 
 (f) Establish and interpret
Performance Measures (or, as applicable, other performance criteria) in connection with Annual Performance Bonuses and Long-Term Performance Awards, evaluate the level of performance over a Performance Cycle and certify the level of performance
attained with respect to Performance Measures (or other performance criteria, as applicable); 
 (g) Subject to Sections 6.1
and 7.12, waive or amend any terms, conditions, restriction or limitation on an Award, except that the prohibition on the repricing of Stock Options and Stock Appreciation Rights, as described in Section 4.3(g), may not be waived; 

(h) Make any adjustments to the Plan (including but not limited to adjustment of the number of Shares available under the Plan or any
Award) and any Award granted under the Plan as may be appropriate pursuant to Section 5.3; 
 (i) Determine and set
forth in the applicable Award Certificate the circumstances under which Awards may be deferred and the extent to which a deferral will be credited with Dividend Equivalents and interest thereon; 
 (j) Determine and set forth in the applicable Award Certificate whether a Nonqualified Stock Option or Restricted Share may be
transferable to family members, a family trust or a family partnership; 
 (k) Establish any subplans and make any
modifications to the Plan, without amending the Plan, or to Awards made hereunder (including the establishment of terms and conditions in the Award Certificate not otherwise inconsistent with the terms of the Plan) that the Committee may determine
to be necessary or advisable for grants made in countries outside the United States to comply with, or to achieve favorable 

  

 - 6 - 

 
tax treatment under, applicable foreign laws or regulations or tax policies or customs; 
 (l) Appoint such agents as it shall deem appropriate for the proper administration of the Plan; and 
 (m) Take any and all other actions it deems necessary or advisable for the proper operation or administration of the Plan. 
 3.3 Effect of Determinations. All determinations of the Committee will be final, binding and conclusive on all persons having an interest in the
Plan. 
 3.4 Delegation of Authority. The Board or, if permitted under applicable corporate law, the Committee, in its discretion and
consistent with applicable law and regulations, may delegate to a committee or an officer or group of officers, as it deems to be advisable, the authority to select Employees to receive an Award and to determine the number of Shares under any such
Award, subject to any terms and conditions that the Board or the Committee may establish. When the Board or the Committee delegates authority pursuant to the foregoing sentence, it will limit, in its discretion, the number or value of Shares that
may be subject to Awards that the delegate may grant. Only the Committee has the authority to grant and administer Awards to Key Employees and other Reporting Persons or to delegates of the Committee, and to establish and certify Performance
Measures. 
 3.5 Employment of Advisors. The Committee may employ attorneys, consultants, accountants and other advisors, and the
Committee, the Company and the officers and directors of the Company may rely upon the advice, opinions or valuations of the advisors employed. 
 3.6 No Liability. No member of the Committee or any person acting as a delegate of the Committee with respect to the Plan will be liable for any losses resulting from any action, interpretation or construction made in good faith with
respect to the Plan or any Award granted under the Plan. 
 ARTICLE IV 
 AWARDS 
 4.1 Eligibility. All Participants and Employees are eligible to
be designated to receive Awards granted under the Plan, except as otherwise provided in this Article IV. 
 4.2 Form of Awards. Awards
will be in the form determined by the Committee, in its discretion, and will be evidenced by an Award Certificate. Awards may be granted singly or in combination or in tandem with other Awards. 
 4.3 Stock Options and Stock Appreciation Rights. The Committee may grant Stock Options and Stock Appreciation Rights under the Plan to those
Employees whom the Committee may from time to time select, in the amounts and pursuant to the other terms and conditions that the Committee, in its discretion, may determine and set forth in the Award Certificate, subject to the provisions below:

 (a) Form. Stock Options granted under the Plan will, at the discretion of the Committee and as set forth in the
Award Certificate, be in the form of Incentive Stock Options, Nonqualified Stock Options or a combination of the two. If an Incentive Stock Option and a Nonqualified Stock Option are granted to the same Participant under the Plan at the same time,
the form of each will be clearly identified, and they will be deemed to have been granted in separate grants. In no event will the exercise of one Award affect the right to exercise the other Award. Stock Appreciation Rights may be granted either
alone or concurrently with Nonqualified Stock Options and the amount of Shares attributable to each Stock Appreciation Right shall be set forth in the applicable Award Certificate on or before the grant date. 
 (b) Exercise Price. The Committee will set the Exercise Price of Stock Options or Stock Appreciation Rights granted under the Plan
at a price that is equal to the Fair Market Value of a Share on the date of grant, subject to adjustment as provided in Section 5.3. The Committee will set the Exercise Price of Premium-Priced Stock Options at a price that is higher than the
Fair Market Value of a Share as of the date of grant, provided that such price is no higher than 150 percent of such Fair Market Value. The Exercise Price of Incentive Stock Options will be equal to or greater than 110 percent of the Fair Market
Value of a Share as of the date of grant if the Participant receiving the Stock Options owns shares possessing more than 10 percent of the total combined voting power of all 

  

 - 7 - 

 
classes of shares of the Company or any subsidiary or parent corporation of the Company, as defined in Section 424 of the Code. The Exercise Price of a
Stock Appreciation Right granted in tandem with a Stock Option will equal the Exercise Price of the related Stock Option. On or before the grant date, the Committee will set forth the Exercise Price of a Stock Option or Stock Appreciation Right in
the Award Certificate or accompanying documentation. Stock Options granted under the Plan will, at the discretion of the Committee and as set forth in the Award Certificate or accompanying documentation, be Stock Options, Premium-Priced Stock
Options or a combination of Stock Options and Premium-Priced Stock Options. 
 (c) Term and Timing of Exercise. Each
Stock Option or Stock Appreciation Right granted under the Plan will be exercisable in whole or in part, subject to the following conditions, unless determined otherwise by the Committee: 
 (i) The term of each Stock Option shall be determined by the Committee and set forth in the applicable Award Certificate, but in no event
shall the term of a Stock Option exceed ten (10) years from the date of its grant. 
 (ii) A Stock Option or Stock
Appreciation Right will become exercisable at such times and in such manner as determined by the Committee and set forth in the applicable Award Certificate. 
 (ii) Unless the applicable Award Certificate provides otherwise, upon the death, Disability, Normal Retirement or a Change in Control
Termination of a Participant who has outstanding Stock Options or Stock Appreciation Rights, the unvested Stock Options or Stock Appreciation Rights will fully vest. Unless the applicable Award Certificate provides otherwise, the Participant’s
Stock Options and Stock Appreciation Rights will lapse, and will not thereafter be exercisable, upon the earlier of (A) their original expiration date or (B) the date that is three (3) years after the date on which the Participant
dies, incurs a Disability or retires due to Normal Retirement. 
 (iii) Unless the applicable Award Certificate provides
otherwise, upon the Termination of Employment of a Participant for any reason other than the Participant’s death, Disability, Normal Retirement or a Change in Control Termination, if the Participant has attained age 55 and the sum of the
Participant’s age and years of service with the Company or a Subsidiary is 60 or higher, a pro rata portion of the Participant’s Stock Options and Stock Appreciation Rights will vest so that the total number of vested Stock Options or
Stock Appreciation Rights held by the Participant at Termination of Employment (including those that have already vested as of such date) will be equal to the total number of Stock Options or Stock Appreciation Rights originally granted to the
Participant under the applicable Award multiplied by a fraction, the numerator of which is the period of time (in whole months) that have elapsed since the date of grant, and the denominator of which is the number of months set forth in the
applicable Award Certificate that is required to attain full vesting. Unless the Award Certificate provides otherwise, such Participant’s Stock Options and Stock Appreciation Rights will lapse, and will not thereafter be exercisable, upon the
earlier of (A) their original expiration date or (B) the date that is three (3) years after the date of Termination of Employment. 
 (iv) Unless the applicable Award Certificate provides otherwise, upon the Termination of Employment of a Participant that does not meet the requirements of paragraphs (ii) or (iii) above, any unvested Stock
Options or Stock Appreciation Rights will be forfeited. Unless the applicable Award Certificate provides otherwise, any Stock Options or Stock Appreciation Rights that are vested as of such Termination of Employment will lapse, and will not
thereafter be exercisable, upon the earlier of (A) their original expiration date or (B) the date that is ninety (90) days after the date of such Termination of Employment. 
 (v) Stock Options and Stock Appreciation Rights of a deceased Participant may be exercised only by the estate of the Participant or by the
person given authority to exercise the Stock Options or Stock Appreciation Rights by the Participant’s will or by operation of law. If a Stock Option or Stock Appreciation Right is exercised by the executor or administrator of a deceased
Participant, or by the person or persons to whom the Stock Option or Stock Appreciation Right has been transferred by the Participant’s will or the applicable laws of descent and distribution, the Company will be under no obligation to deliver
Shares or cash until the Company is satisfied that the person exercising the Stock Option or Stock Appreciation Right is the duly appointed executor or administrator of the deceased 

  

 - 8 - 

 
Participant or the person to whom the Stock Option or Stock Appreciation Right has been transferred by the Participant’s will or by applicable laws of
descent and distribution. 
 (vi) A Stock Appreciation Right granted in tandem with a Stock Option is subject to the same
terms and conditions as the related Stock Option and will be exercisable only to the extent that the related Stock Option is exercisable. 
 (d) Payment of Exercise Price. The Exercise Price of a Stock Option must be paid in full when the Stock Option is exercised. Shares will be issued and delivered only upon receipt of payment. Payment of the
Exercise Price may be made in cash or by certified check, bank draft, wire transfer, or postal or express money order, provided that the format is approved by the Company or a designated third-party administrator. The Committee, in its discretion
may also allow payment to be made by any of the following methods, as set forth in the applicable Award Certificate: 
 (i)
Delivering a properly executed exercise notice to the Company or its agent, together with irrevocable instructions to a broker to deliver to the Company, within the typical settlement cycle for the sale of equity securities on the relevant trading
market (or otherwise in accordance with the provisions of Regulation T issued by the Federal Reserve Board), the amount of sale proceeds with respect to the portion of the Shares to be acquired having a Fair Market Value on the date of exercise
equal to the sum of the applicable portion of the Exercise Price being so paid; 
 (ii) Subject to any requirements of
applicable law and regulations, tendering (actually or by attestation) to the Company or its agent previously acquired Shares that have a Fair Market Value on the day prior to the date of exercise equal to the applicable portion of the Exercise
Price being so paid; or 
 (iii) Subject to any requirements of applicable law and regulations, instructing the Company to
reduce the number of Shares that would otherwise be issued by such number of Shares as have in the aggregate a Fair Market Value on the date of exercise equal to the applicable portion of the Exercise Price being so paid. 
 (e) Incentive Stock Options. Incentive Stock Options granted under the Plan will be subject to the following additional conditions,
limitations and restrictions: 
 (i) Eligibility. Incentive Stock Options may be granted only to Employees of the
Company or a Subsidiary that is a subsidiary or parent corporation of the Company within the meaning of Code Section 424. 
 (ii) Timing of Grant. No Incentive Stock Option will be granted under the Plan after the 10-year anniversary of the date on which the Plan is adopted by the Board or, if earlier, the date on which the Plan is approved by the
stockholders of Covidien Ltd. 
 (iii) Amount of Award. Subject to Section 5.3 of the Plan, no more than
10 million Shares may be available for grant in the form of Incentive Stock Options. The aggregate Fair Market Value (as of the date of grant) of the Shares with respect to which the Incentive Stock Options awarded to any Employee first become
exercisable during any calendar year may not exceed $100,000 (U.S.). For purposes of this $100,000 (U.S.) limit, the Employee’s Incentive Stock Options under this Plan and all other plans maintained by the Company and its Subsidiaries will be
aggregated. To the extent any Incentive Stock Option would exceed the $100,000 (U.S.) limit, the Incentive Stock Option will afterwards be treated as a Nonqualified Stock Option to the extent required by the Code and underlying regulations and
rulings. 
 (iv) Timing of Exercise. If the Committee exercises its discretion in the Award Certificate to permit an
Incentive Stock Option to be exercised by a Participant more than three months after the Participant has ceased being an Employee (or more than 12 months if the Participant is permanently and totally disabled, within the meaning of Code
Section 22(e)), the Incentive Stock Option will afterwards be treated as a Nonqualified Stock Option to the extent required by the Code and underlying regulations and rulings. For purposes of this paragraph (iv), an Employee’s employment
relationship will be treated as continuing intact while the Employee is on military leave, sick leave or another approved leave of absence if the 

  

 - 9 - 

 
period of leave does not exceed 90 days, or a longer period to the extent that the Employee’s right to reemployment with the Company or a Subsidiary is
guaranteed by statute or by contract. If the period of leave exceeds 90 days and the Employee’s right to reemployment is not guaranteed by statute or contract, the employment relationship will be deemed to have ceased on the 91st day of the
leave. 
 (v) Transfer Restrictions. In no event will the Committee permit an Incentive Stock Option to be transferred
by an Employee other than by will or the laws of descent and distribution, and any Incentive Stock Option awarded under this Plan will be exercisable only by the Employee during the Employee’s lifetime. 
 (f) Exercise of Stock Appreciation Rights. Upon exercise of a Participant’s Stock Appreciation Rights, the Company will pay
cash or Shares or a combination of cash and Shares, in the discretion of the Committee and as described in the Award Certificate. Cash payments will be equal to the excess of the Fair Market Value of a Share on the date of exercise over the Exercise
Price, for each Share for which a Stock Appreciation Right was exercised. If Shares are paid for the Stock Appreciation Right, the Participant will receive a number of whole Shares equal to the quotient of the cash payment amount divided by the Fair
Market Value of a Share on the date of exercise. 
 (g) No Repricing. Except as otherwise provided in Section 5.3,
in no event will the Committee decrease the Exercise Price of a Stock Option or Stock Appreciation Right after the date of grant or cancel outstanding Stock Options or Stock Appreciation Rights and grant replacement Stock Options or Stock
Appreciation Rights with a lower Exercise Price than that of the replaced Stock Options or Stock Appreciation Rights or other Awards without first obtaining the approval of the holders of a majority of the Shares who are present in person or by
proxy at a meeting of the Company’s shareholders and entitled to vote. 
 4.4 Annual Performance Bonuses. The Committee may grant
Annual Performance Bonuses under the Plan in the form of cash or Shares to the Reporting Persons that the Committee may from time to time select, in the amounts and pursuant to the terms and conditions that the Committee may determine and set forth
in the Award Certificate, subject to the provisions below: 
 (a) Performance Cycles. Annual Performance Bonuses will
be awarded in connection with a twelve (12) month Performance Cycle, which will be the fiscal year of the Company. 
 (b)
Eligible Participants. Within ninety (90) days after the commencement of a Performance Cycle, the Committee will determine the Reporting Persons who will be eligible to receive an Annual Performance Bonus under the Plan. If an individual
becomes a Reporting Person after this ninety (90) day period, the Committee may determine that such Reporting Person is eligible to receive a pro rata Annual Performance Bonus under the Plan. 
 (c) Performance Measures; Targets; Award Criteria.  
 (i) Within ninety (90) days after the commencement of the service period to which a Performance Cycle relates, the Committee will fix
and establish in writing (A) the Performance Measures that will apply to that Performance Cycle; (B) the Target Amount payable to each Participant; and (C) subject to subsection (d) below, the criteria for computing the amount
that will be paid with respect to each level of attained performance. The Committee will also set forth the minimum level of performance, based on objective factors, that must be attained during the Performance Cycle before any Annual Performance
Bonus will be paid and the percentage of the Target Amount that will become payable upon attainment of various levels of performance that equal or exceed the minimum required level. 
 (ii) The Committee may, in its discretion, select Performance Measures that measure the performance of the Company or one or more business
units, divisions or Subsidiaries of the Company. The Committee may select Performance Measures that are absolute or relative to the performance of one or more comparable companies or an index of comparable companies. 
 (iii) The Committee, in its discretion, may, on a case-by-case basis, reduce, but not increase, the amount payable to any Key Employee
with respect to any given Performance Cycle, provided, however, that no reduction will result in an increase in the amount payable under any Annual Performance Bonus of another Key Employee. 
  

 - 10 - 

 (d) Payment, Certification. No Annual Performance Bonus will vest with respect to
any Reporting Person until the Committee certifies in writing the level of performance attained for the Performance Cycle in relation to the applicable Performance Measures. In applying Performance Measures, the Committee may, in its discretion,
exclude unusual or infrequently occurring items (including any event listed in Section 5.3 and the cumulative effect of changes in the law, regulations or accounting rules), and may determine no later than ninety (90) days after the
commencement of any applicable Performance Cycle to exclude other items, each determined in accordance with GAAP (to the extent applicable). 
 (e) Form of Payment. Annual Performance Bonuses will be paid in cash or Shares. All such Performance Bonuses shall be paid no later than the 15th day of the third month following the end of the calendar year
(or, if later, following the end of the Company’s fiscal year) in which such Performance Bonuses are no longer subject to a substantial risk of forfeiture (as determined for purposes of Section 409A of the Code), except to the extent that
a Participant has elected to defer payment under the terms of a duly authorized deferred compensation arrangement, in which case the terms of such arrangement shall govern. 
 (f) Section 162(m) of the Code. It is the intent of the Company that Annual Performance Bonuses be
“performance-based compensation” for purposes of Section 162(m) of the Code, that this Section 4.4 be interpreted in a manner that satisfies the applicable requirements of Section 162(m)(4)(C) of the Code and related
regulations, and that the Plan be operated so that the Company may take a full tax deduction for Annual Performance Bonuses. If any provision of this Plan or any Annual Performance Bonus would otherwise frustrate or conflict with this intent, the
provision will be interpreted and deemed amended so as to avoid this conflict. 
 (g) Acceleration. Each Participant
who is eligible to receive an Annual Performance Bonus with respect to a Performance Cycle during which a Change of Control occurs will, except as otherwise provided below, be deemed to have achieved a level of performance, as of the date of Change
in Control, that would cause all (100%) of the Participant’s Target Amount to become payable at such times and in such manner as determined in the sole discretion of the Committee. Notwithstanding the previous sentence, if (i) a
surviving entity maintains the Performance Cycle in which a Change in Control occurs, or otherwise provides for the payment of an Annual Performance Bonus based on the level of performance attained for such Performance Cycle in relation to the
Performance Measures established for such Performance Cycle (including Performance Measures that were adjusted or modified as a result of the Change in Control) and (ii) the Annual Performance Bonus based on the level of performance attained
for such Performance Cycle exceeds all (100%) of the Participant’s Target Amount, then each Participant who is eligible to receive an Annual Performance Bonus with respect to such Performance Cycle shall receive an Annual Performance Bonus
based on the level of performance attained for such Performance Cycle at such times and in such manner as determined in the sole discretion of the Committee, or successor to the Committee. The time and manner of any payments made pursuant to this
Section 4.4(g) shall comply with Section 4.4(e) above. 
 4.5 Long-Term Performance Awards. The Committee may grant
Long-Term Performance Awards under the Plan in the form of Performance Units, Restricted Units or Restricted Stock to any Employee who the Committee may from time to time select, in the amounts and pursuant to the terms and conditions that the
Committee may determine and set forth in the Award Certificate, subject to the provisions below: 
 (a) Performance Cycles.
Long-Term Performance Awards will be awarded in connection with a Performance Cycle, as determined by the Committee in its discretion, provided, however, that a Performance Cycle may be no shorter than twelve (12) months and no longer than
five (5) years. 
 (b) Eligible Participants. Within ninety (90) days after the commencement of a Performance
Cycle, the Committee will determine the Employees who will be eligible to receive a Long-Term Performance Award for the Performance Cycle, provided that the Committee may determine the eligibility of any Employee other than a Key Employee after the
expiration of this ninety (90) day period. 
  

 - 11 - 

 (c) Performance Measures; Targets; Award Criteria.  
 (i) Within ninety (90) days after the commencement of the service period to which a Performance Cycle relates, the Committee will fix
and establish in writing (A) the Performance Measures that will apply to that Performance Cycle; (B) with respect to Performance Units, the Target Amount payable to each Participant; (C) with respect to Restricted Units and Restricted
Stock, the Target Vesting Percentage for each Participant; and (D) subject to subsection (d) below, the criteria for computing the amount that will be paid or will vest with respect to each level of attained performance. The Committee will
also set forth the minimum level of performance, based on objective factors, that must be attained during the Performance Cycle before any Long-Term Performance Award will be paid or vest, and the percentage of Performance Units that will become
payable and the percentage of performance-based Restricted Units or Shares of Restricted Stock that will vest upon attainment of various levels of performance that equal or exceed the minimum required level. 
 (ii) The Committee may, in its discretion, select Performance Measures that measure the performance of the Company or one or more business
units, divisions or Subsidiaries of the Company. The Committee may select Performance Measures that are absolute or relative to the performance of one or more comparable companies or an index of comparable companies. 
 (iii) The Committee, in its discretion, may, on a case-by-case basis, reduce, but not increase, the amount of Long-Term Performance Awards
payable to any Key Employee with respect to any given Performance Cycle, provided, however, that no reduction will result in an increase in the dollar amount or number of Shares payable under any Long-Term Performance Award of another Key Employee.

 (iv) With respect to Employees who are not Key Employees, the Committee may establish, in its discretion, performance
criteria other than the Performance Measures that will be applicable for the Performance Cycle. 
 (d) Payment,
Certification. No Long-Term Performance Award will vest with respect to any Employee until the Committee certifies in writing the level of performance attained for the Performance Cycle in relation to the applicable Performance Measures.
Long-Term Performance Awards awarded to Participants who are not Key Employees will be based on the Performance Measures, or other applicable performance criteria, and payment formulas that the Committee, in its discretion, may establish for these
purposes. These Performance Measures, or other performance criteria, and formulas may be the same as or different than the Performance Measures and formulas that apply to Key Employees. 
 In applying Performance Measures, the Committee may, in its discretion, exclude unusual or infrequently occurring items (including any
event listed in Section 5.3 and the cumulative effect of changes in the law, regulations or accounting rules, and may determine no later than ninety (90) days after the commencement of any applicable Performance Cycle to exclude other
items, each determined in accordance with GAAP (to the extent applicable) and as identified in the financial statements, notes to the financial statements or discussion and analysis of management. 
 (e) Form of Payment. Long-Term Performance Awards in the form of Performance Units may be paid in cash or full Shares, in the
discretion of the Committee, and as set forth in the applicable Award Certificate. Performance-based Restricted Units and Restricted Stock will be paid in full Shares. Payment with respect to any fractional Share will be in cash in an amount based
on the Fair Market Value of the Share as of the date the Performance Unit becomes payable. All Long-Term Performance Awards shall be paid no later than the 15th day of the third month following the end of the calendar year (or, if later, following
the end of the Company’s fiscal year) in which such Long-Term Performance Awards are no longer subject to a substantial risk of forfeiture (within the meaning of Code Section 409A), except to the extent that a Participant has elected to
defer payment under the terms of a duly authorized deferred compensation arrangement, in which case the terms of such arrangement shall govern, or as otherwise provided in Section 4.5(g) below. 
 (f) Section 162(m) of the Code. It is the intent of the Company that Long-Term Performance Awards made to Key Employees be
“performance-based compensation” for purposes of Section 162(m) of the Code, that this 

  

 - 12 - 

 
Section 4.5 be interpreted in a manner that satisfies the applicable requirements of Section 162(m)(4)(C) of the Code and related regulations with
respect to Long-Term Performance awards made to Key Employees, and that the Plan be operated so that the Company may take a full tax deduction for Long-Term Performance Awards. If any provision of this Plan or any Long-Term Performance Award would
otherwise frustrate or conflict with this intent, the provision will be interpreted and deemed amended so as to avoid this conflict. 
 (g) Special Vesting Provisions. Unless the applicable Award Certificate provides otherwise, upon the death, Disability, Normal Retirement or a Change in Control Termination of a Participant who has an outstanding Long-Term
Performance Award, the unvested Long-Term Performance Award will fully vest when the Committee certifies the performance criteria for the applicable Performance Period have been satisfied. Unless the applicable Award Certificate provides otherwise,
upon the Termination of Employment of a Participant for any reason other than the Participant’s death, Disability, Normal Retirement or a Change in Control Termination, the unvested Long-Term Performance Award will be forfeited unless the
Participant has attained age 55 and the sum of the Participant’s age and years of service with the Company or a Subsidiary is 60 or higher, in which case a pro rata portion of the Participant’s Long-Term Performance Awards will vest on the
date the Committee certifies the performance criteria for the applicable Performance Period have been satisfied so that the total number of vested Long-Term Performance Awards held by the Participant on such date shall equal the total number of
Long-Term Performance Awards in which such Participant would have vested had such Participant remained in active employment with the Company or any Subsidiary until the date the Committee certifies the performance criteria for the applicable
Performance Period have been satisfied and after adjustment for the attained level of performance multiplied by a fraction, the numerator of which is the period of time (in whole months) that have elapsed since the date of grant, and the denominator
of which is the number of total months set forth in the applicable Award Certificate for such Performance Period. 
 4.6 Other Stock-Based
Awards. The Committee may, from time to time, grant Awards (other than Stock Options, Stock Appreciation Rights, Annual Performance Bonuses or Long-Term Performance Awards) to any Employee who the Committee may from time to time select, which
Awards consist of, or are denominated in, payable in, valued in whole or in part by reference to, or otherwise related to, Shares. These Awards may include, among other forms, Restricted Stock, Restricted Units, or Deferred Stock Units. The
Committee will determine, in its discretion, the terms and conditions that will apply to Awards granted pursuant to this Section 4.6, which terms and conditions will be set forth in the applicable Award Certificate. 
 (a) Vesting. Restrictions on Other Stock-Based Awards granted under this Section 4.6 will lapse at such times and in such
manner as determined by the Committee and set forth in the applicable Award Certificate. Unless the applicable Award Certificate provides otherwise, if the restrictions on Other Stock-Based Awards have not lapsed or been satisfied as of the
Participant’s Termination of Employment, the Shares will be forfeited by the Participant if the termination is for any reason other than the Normal Retirement, death or Disability of the Participant or a Change in Control Termination, except
that the Award will vest pro rata with respect to the portion of the vesting term set forth in the applicable Award Certificate that the Participant has completed if the Participant has attained age 55 and the sum of the Participant’s age and
years of service with the Company is 60 or higher. All restrictions on Other Stock-Based Awards granted pursuant to this Section 4.6 will lapse upon the Normal Retirement, death or Disability of the Participant or a Change in Control
Termination. 
 (b) Grant of Restricted Stock. The Committee may grant Restricted Stock to any Employee, which Shares
will be registered in the name of the Participant and held for the Participant by the Company. The Participant will have all rights of a shareholder with respect to the Shares, including the right to vote and to receive dividends or other
distributions, except that the Shares may be subject to a vesting schedule and will be forfeited if the Participant attempts to sell, transfer, assign, pledge or otherwise encumber or dispose of the Shares before the restrictions are satisfied or
lapse. 
 (c) Grant of Restricted Units. The Committee may grant Restricted Units to any Employee, which Units will be
paid in cash or whole Shares or a combination of cash and Shares, in the discretion of the Committee, when the restrictions on the Units lapse and any other conditions set forth in the Award Certificate have been satisfied. For each Restricted Unit
that vests, one Share will be paid or an amount in cash equal to the Fair Market Value of a Share as of the date on which the Restricted Unit vests. 
 (d) Grant of Deferred Stock Units. The Committee may grant Deferred Stock Units to any Employee, which 

  

 - 13 - 

 
Units will be paid in whole Shares upon the Employee’s Termination of Employment if the restrictions on the Units have lapsed. One Share will be paid
for each Deferred Stock Unit that becomes payable. 
 (e) Dividends and Dividend Equivalents. At the discretion of the
Committee and as set forth in the applicable Award Certificate, dividends paid on Shares may be paid immediately or withheld and deferred in the Participant’s account. In the event of a payment of dividends on the Ordinary Shares, the Committee
may credit Restricted Units with Dividend Equivalents in accordance with terms and conditions established in the discretion of the Committee. Dividend Equivalents will be subject to such vesting terms as is determined by the Committee and may be
distributed immediately or withheld and deferred in the Participant’s account as determined by the Committee and set forth in the applicable Award Certificate. Deferred Stock Units may, in the discretion of the Committee and as set forth in the
Award Certificate, be credited with Dividend Equivalents or additional Deferred Stock Units. The number of any Deferred Stock Units credited to a Participant’s account upon the payment of a dividend will be equal to the quotient produced by
dividing the cash value of the dividend by the Fair Market Value of one Share as of the date the dividend is paid. The Committee will determine any terms and conditions on deferral of a dividend or Dividend Equivalent, including the rate of interest
to be credited on deferral and whether interest will be compounded. 
 4.7 Director Awards.  
 (a) Notwithstanding anything herein to the contrary, the Nominating Committee shall have the exclusive authority to issue awards to
Directors (Director Awards), which may consist of, but not be limited to, Stock Options, Stock Appreciation Rights, or Other Stock-Based Awards. Each Director Award shall be governed by an Award Certificate approved by the Nominating Committee.

 (b) The Nominating Committee shall have the exclusive authority to administer Director Awards, and shall have the authority
set forth in Section 3.2 and the indemnification set forth in Section 7.7, solely as such provisions apply to the Director Awards. All determinations made by the Nominating Committee hereunder shall be final, binding and conclusive.

 4.8 Substitute Awards. The Committee may make Awards under the Plan to Acquired Grantees through the assumption of, or in
substitution for, outstanding stock-based awards previously granted to such Acquired Grantees. Such assumed or substituted Awards will be subject to the terms and conditions of the original awards made by the Acquired Company, with such adjustments
therein as the Committee considers appropriate to give effect to the relevant provisions of any agreement for the acquisition of the Acquired Company. Any grant of Incentive Stock Options pursuant to this Section 4.8 will be made in accordance
with Section 424 of the Code and any final regulations published thereunder. 
 4.9 Limit on Individual Grants. Subject to
Sections 5.1 and 5.3, no Employee may be granted more than six (6) million Shares over any calendar year pursuant to Awards of Stock Options, Stock Appreciation Rights and performance-based Restricted Stock and Restricted Units, except that an
incentive Award of no more than ten (10) million Shares may be made pursuant to Stock Options, Stock Appreciation Rights and performance-based Restricted Stock and Restricted Units to any person who has been hired within the calendar year as a
Key Employee. The maximum amount that may be paid in cash or Shares pursuant to Annual Performance Bonuses or Long-Term Performance Awards paid in Performance Units to any one Employee is $15 million (U.S.) for any Performance Cycle of twelve
(12) months. For any longer Performance Cycle, this maximum will be adjusted proportionally. 
 4.10 Termination for Cause.
Notwithstanding anything to the contrary herein and unless the applicable Award Certificate provides otherwise, if a Participant incurs a Termination of Directorship or Termination of Employment for Cause, then all Stock Options, Stock
Appreciation Rights, Annual Performance Bonuses, Long-Term Performance Awards, Restricted Units, Restricted Stock and Other Stock-Based Awards will immediately be cancelled. The exercise of any Stock Option or Stock Appreciation Right or the payment
of any Award may be delayed, in the Committee’s discretion, in the event that a potential termination for Cause is pending. Unless the applicable Award Certificate provides otherwise, if a Participant incurs a Termination of Directorship or
Termination of Employment for Cause, then the Participant will be required to deliver to the Company (i) Shares (or, in the discretion of the Committee, cash) equal in value to the amount of any profit the Participant realized upon the exercise
of an Option or Stock Appreciate Right during the twelve (12) month period occurring immediately prior to the Participant’s Termination of Directorship or Termination of Employment for Cause; and (ii) the number of Shares (or, in the
discretion of the Committee, the cash value of Shares) the Participant received for Other Stock Based Awards (including Restricted Stock, Restricted Units and Deferred Stock Units) that vested 

  

 - 14 - 

 
during the period specified in (i) above. Unless the applicable award certificate provides otherwise, if, after a Participant’s Termination of
Directorship or Termination of Employment, the Committee determines in its sole discretion that while the Participant was a Company or Subsidiary employee or a Director, such Participant engaged in activity that would have been grounds for a
Termination of Directorship or Termination of Employment for Cause, then the Company will immediately cancel all Stock Options, Stock Appreciation Rights, Annual Performance Bonuses, Long-Term Performance Awards, Restricted Units, Restricted Stock
and Other Stock-Based Awards and the Participant will be required to deliver to the Company (A) Shares (or, in the discretion of the Committee, cash) equal in value to the amount of any profit the Participant realized upon the exercise of an
Option or Stock Appreciate Right during the period that begins twelve (12) months immediately prior to the Participant’s Termination of Directorship or Termination of Employment and ends on the date of the Committee’s determination
that the Participant’s conduct would have constituted grounds for a Termination of Directorship or Termination of Employment for Cause; and (B) the number of Shares (or, in the discretion of the Committee, the cash value of said shares)
the Participant received for Other Stock Based Awards (including Restricted Stock, Restricted Units and Deferred Stock Units) that vested during the period specified in (A) above. 
 ARTICLE V 
 SHARES SUBJECT TO THE PLAN; ADJUSTMENTS 
 5.1 Shares Available. The Shares issuable under the Plan will be authorized but unissued Shares, and, to the extent permissible under applicable
law, Shares acquired by the Company, any Subsidiary or any other person or entity designated by the Company. The total number of Shares with respect to which Awards may be issued under the Plan may equal, but may not exceed 35 million, subject
to adjustment in accordance with Section 5.3; provided that when Shares are issued pursuant to a grant of Restricted Stock, Restricted Units, Deferred Stock Units, Performance Units or as payment of an Annual Performance Bonus or Other
Stock-Based Award, the total number of Shares remaining available for grant will be decreased by a margin of at least 1.8 per Share issued. No more than 10 million Shares of the total Shares issuable under the Plan may be available for
grant in the form of Incentive Stock Options. 
 5.2 Counting Rules. The following Shares related to Awards under this Plan may again
be available for issuance under the Plan, in addition to the Shares described in Section 5.1: 
 (a) Shares related to
Awards paid in cash; 
 (b) Shares related to Awards that expire, are forfeited or cancelled or terminate for any other reason
without issuance of Shares; 
 (c) Any Shares issued in connection with Awards that are assumed, converted or substituted as a
result of the acquisition of an Acquired Company by the Company or a combination of the Company with another company; and 
 (d) Any Shares of Restricted Stock that are returned to the Company upon a Participant’s Termination of Employment or, if applicable, a Director’s Termination of Directorship. 
 5.3 Adjustments. In the event of a change in the outstanding Shares by reason of a share split, reverse share split, dividend or other
distribution (whether in the form of cash, Shares, other securities or other property), extraordinary cash dividend, recapitalization, merger, consolidation, split-up, spin-off, reorganization, combination, repurchase or exchange of Shares or other
securities or similar corporate transaction or event, the Committee shall make an appropriate adjustment to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan. Any adjustment made by
the Committee under this Section 5.3 will be conclusive and binding for all purposes under the Plan. 
 5.4 Change in Control.

 (a) Acceleration. Unless the applicable Award Certificate provides otherwise, (i) all outstanding Stock Options
and Stock Appreciation Rights will become exercisable as of the effective date of a Participant’s Change in Control Termination if the Awards are not otherwise vested, and all conditions will be waived with respect to outstanding Restricted
Stock and Restricted Units (other than Long-Term Performance Awards) and Deferred Stock Units and (ii) each Participant who has been granted a Long-Term Performance Award that is outstanding as of the date of such Participant’s Change in
Control Termination will be deemed to have achieved a level of performance, as of the Change in Control Termination, that would cause all (100%) of the Participant’s Target 

  

 - 15 - 

 
Amounts to become payable and all restrictions on the Participant’s performance-based Restricted Units and Shares of Restricted Stock to lapse. Unless
the Committee determines otherwise in its discretion (either when an Award is granted or any time thereafter), in the event that Awards outstanding as of the date of a Change in Control that are payable in Ordinary Shares of the Company will not be
substituted with comparable awards payable or redeemable in shares of publicly-traded shares after the Change in Control, each such outstanding Award (A) will become fully vested (at target, where applicable) immediately prior to the Change in
Control and (B) each such Award that is a Stock Option will be settled in cash, without the Participant’s consent, for an amount equal to the amount that could have been attained upon the exercise of such Award immediately prior to the
Change in Control had such Award been exercisable or payable at such time. 
 (b) Permissive Actions. In addition to
the actions described in Section 5.4(a)(A) and (B), in the event of a Change in Control, the Committee may take any one or more of the following actions with respect to any or all outstanding Awards, without the consent of Participants:
(i) the Committee may determine that outstanding Stock Options and Stock Appreciation Rights shall be fully vested and exercisable and restrictions on Restricted Stock, Restricted Units, Deferred Stock Units and Other Stock-Based Awards shall
lapse as of the date of the Change in Control or such other time (prior to a Participant’s Change in Control Termination) as the Committee determines; (ii) the Committee may require that a Participant surrender his or her outstanding Stock
Options and Stock Appreciation Rights in exchange for one or more payments by the Company, in cash or Ordinary Shares, as determined by the Committee, in an amount equal to the amount by which the then Fair Market Value of the Shares subject to the
Participant’s unexercised Stock Options and Stock Appreciation Rights exceeds the Exercise Price, if any, and on such terms as the Committee determines; (iii) after giving Participants an opportunity to exercise any outstanding Stock
Options and Stock Appreciation Rights, the Committee may terminate any or all unexercised Stock Options and Stock Appreciation Rights at such time as the Committee deems appropriate; (iv) the Committee may determine that Annual Performance
Bonuses and/or Long-Term Performance Awards will be paid out at their target level, in cash or Ordinary Shares as determined by the Committee; or (v) the Committee may determine that Awards that remain outstanding after the Change in Control
shall be converted to similar grants of, or assumed by, the surviving corporation (or a parent or subsidiary of the surviving corporation or successor). Such acceleration, surrender, termination, settlement, payment or conversion shall take place as
of the date of the Change in Control or such other date as the Committee determines. The Committee may specify how an Award will be treated in the event of a Change in Control either when the Award is granted or at any time thereafter. 

5.5 Fractional Shares. No fractional Shares will be issued under the Plan. Except as otherwise provided in Section 4.5(e) and unless
otherwise provided by the Committee, if a Participant acquires the right to receive a fractional Share under the Plan, the Participant will receive, in lieu of the fractional Share, a full Share as of the date of settlement. 
 ARTICLE VI 
 AMENDMENT AND
TERMINATION 
 6.1 Amendment. The Plan may be amended at any time and from time to time by the Board or authorized Board committee
without the approval of shareholders of the Company, except that no material revision to the terms of the Plan will be effective until the amendment is approved by the shareholders of the Company. A revision is “material” for this purpose
if, among other changes, it materially increases the number of Shares that may be issued under the Plan (other than an increase pursuant to Section 5.3 of the Plan), expands the types of Awards available under the Plan, materially expands the
class of persons eligible to receive Awards under the Plan, materially extends the term of the Plan, materially decreases the Exercise Price at which Stock Options or Stock Appreciation Rights may be granted, reduces the Exercise Price of
outstanding Stock Options or Stock Appreciation Rights, or results in the replacement of outstanding Stock Options and Stock Appreciation Rights with new Awards that have an Exercise Price that is lower than the Exercise Price of the replaced Stock
Options and Stock Appreciation Rights. No amendment of the Plan or any outstanding Award Certificate made without the Participant’s written consent may adversely affect any right of a Participant with respect to an outstanding Award.

 6.2 Termination. The Plan will terminate upon the earlier of the following dates or events to occur: 
 (a) the adoption of a resolution of the Board terminating the Plan; or 
 (b) November 20, 2018, the day before the tenth (10th) anniversary of the adoption of the November 21, 2008 

  

 - 16 - 

 
amendment and restatement of the Plan which was approved by the shareholders of Covidien Ltd. at its 2009 annual general meeting held on March 18, 2009.

 No Awards will be granted under this Plan after it has terminated. The termination of the Plan, however, will not alter or impair any of the rights or
obligations of any person under any Award previously granted under the Plan without such person’s consent. After the termination of the Plan, any previously granted Awards will remain in effect and will continue to be governed by the terms of
the Plan and the applicable Award Certificate. 
 ARTICLE VII 
 GENERAL PROVISIONS 
 7.1 Nontransferability of Awards. No Award under the
Plan will be subject in any manner to alienation, anticipation, sale, assignment, pledge, encumbrance or transfer, and no other persons will otherwise acquire any rights therein, except as provided below. 
 (a) Any Award may be transferred by will or by the laws of descent or distribution. 
 (b) Unless the applicable Award Certificate provides otherwise, all or any part of a Nonqualified Stock Option or Shares of Restricted
Stock may be transferred to a family member. For purposes of this subsection (b), “family member” includes any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law of the Participant, including adoptive relationships, any person sharing the Participant’s household (other than a tenant or employee), a trust in which these persons
have more than fifty percent (50%) of the beneficial interest, a foundation in which these persons (or the Participant) control the management of assets, and any other entity in which these persons (or the Participant) own more than fifty
percent (50%) of the voting interests. 
 Any transferred Award will be subject to all of the same terms and conditions
as provided in the Plan and the applicable Award Certificate. The Participant or the Participant’s estate will remain liable for any withholding tax that may be imposed by any federal, state or local tax authority. The Company may, in its sole
discretion, disallow all or a part of any transfer of an Award pursuant to this Subsection 7.1(b) unless and until the Participant makes arrangements satisfactory to the Company for the payment of any withholding tax. The Participant must
immediately notify the Company, in the form and manner required by the applicable Award Certificate or as otherwise required by the Company, of any proposed transfer of an Award pursuant to this Subsection 7.1(b). No transfer will be effective until
the Company consents to the transfer. 
 (c) Unless the applicable Award Certificate provides otherwise, any Nonqualified
Stock Option transferred by a Participant pursuant to subsection (b) may be exercised by the transferee only to the extent that the Award would have been exercisable by the Participant had no transfer occurred. The transfer of Shares upon
exercise of the Award will be conditioned on the payment of any withholding tax. 
 (d) Restricted Stock may be freely
transferred after the restrictions lapse or are satisfied and the Shares are delivered, provided, however, that Restricted Stock awarded to an affiliate of the Company may be transferred only pursuant to Rule 144 under the Securities Act, or
pursuant to an effective registration for resale under the Securities Act. For purposes of this subsection (d), “affiliate” will have the meaning assigned to that term under Rule 144. 
 (e) In no event may a Participant transfer an Incentive Stock Option other than by will or the laws of descent and distribution.

 7.2 Withholding of Taxes. The Committee, in its discretion, may require the satisfaction of a Participant’s tax withholding
obligations by any of the following methods or any method as it determines to be in accordance with the laws of the jurisdiction in which the Participant resides, has domicile or performs services. 
 (a) Stock Options and Stock Appreciation Rights. As a condition to the delivery of Shares pursuant to the exercise of a Stock
Option or Stock Appreciation Right, the Committee may require that the Participant, at the time of exercise, pay to the Company by cash, certified check, bank draft, wire transfer or postal or express money order an amount sufficient to satisfy any
applicable tax withholding obligations. The Committee may also, in its 

  

 - 17 - 

 
discretion, accept payment of tax withholding obligations through any of the Exercise Price payment methods described in Section 4.3(d). 
 (b) Other Awards Payable in Shares. The Participant shall satisfy the Participant’s tax withholding obligations arising in
connection with the release of restrictions on Restricted Units, Restricted Stock and Other Stock-Based Awards by payment to the Company in cash or by certified check, bank draft, wire transfer or postal or express money order, provided that the
format is approved by the Company or a designated third-party administrator. However, subject to any requirements of applicable law, the Company may also satisfy the Participant’s tax withholding obligations by other methods, including selling
or withholding Shares that would otherwise be available for delivery. 
 (c) Cash Awards. The Company may satisfy a
Participant’s tax withholding obligation arising in connection with the payment of any Award in cash by withholding cash from such payment. 
 7.3 Special Forfeiture Provision. The Committee may, in its discretion, provide in an Award Certificate that the Participant may not, within two (2) years after the Participant’s Termination of Employment, enter into any
employment or consultation arrangement (including service as an agent, partner, shareholder, consultant, officer or director) with any entity or person engaged in any business in which the Company or any Subsidiary is engaged without prior written
approval of the Committee if, in the sole judgment of the Committee, the business is competitive with the Company or any Subsidiary or business unit or such employment or consultation arrangement would present a risk that the Participant would
likely disclose Company proprietary information (as determined in the sole discretion of the Committee). If the Committee makes a determination that this prohibition has been violated, unless the Award Certificate otherwise provides, the Participant
(i) will forfeit all rights under any outstanding Stock Option or Stock Appreciation Right that was granted subject to the Award Certificate and will return to the Company the amount of any profit realized upon an exercise of all Awards during
the period, as the Committee determines and sets forth in the Award Certificate, beginning no earlier than twelve (12) months prior to the Participant’s Termination of Employment, and (ii) will forfeit and return to the Company any
Annual Performance Bonuses, Performance Units, Shares of Restricted Stock, Restricted Units (including any credited Dividend Equivalents), Deferred Stock Units, and Other Stock-Based Awards that are outstanding on the date of the Participant’s
Termination of Employment, subject to the Award Certificate, and have not vested or that became vested and remain subject to this Section 7.3 during a period, as the Committee determines and sets forth in the Award Certificate, beginning no
earlier than twelve (12) months prior to the Participant’s Termination of Employment. 
 7.4 No Implied Rights. The
establishment and operation of the Plan, including the eligibility of a Participant to participate in the Plan, will not be construed as conferring any legal or other right upon any Director for any continuation of directorship or any Employee for
the continuation of employment through the end of any Performance Cycle or other period. The Company expressly reserves the right, which may be exercised at any time and in the Company’s sole discretion, to discharge any individual or treat him
or her without regard to the effect that discharge might have upon him or her as a Participant in the Plan. 
 7.5 No Obligation to
Exercise Awards. The grant of a Stock Option or Stock Appreciation Right will impose no obligation upon the Participant to exercise the Award. 
 7.6 No Rights as Shareholders. A Participant who is granted an Award under the Plan will have no rights as a shareholder of the Company with respect to the Award unless and until certificates for the Shares underlying the Award are
registered in the Participant’s name and (other than in the case of Restricted Stock) delivered to the Participant. The right of any Participant to receive an Award by virtue of participation in the Plan will be no greater than the right of any
unsecured general creditor of the Company. 
 7.7 Indemnification of Committee. The Company will indemnify, to the fullest extent
permitted by law, each person made or threatened to be made a party to any civil or criminal action or proceeding by reason of the fact that the person, or the executor or administrator of the person’s estate, is or was a member of the
Committee or an authorized delegate of the Committee including, for purposes of Director Awards, the Nominating Committee. 
 7.8 No
Required Segregation of Assets. Neither the Company nor any Subsidiary will be required to segregate any assets that may at any time be represented by Awards granted pursuant to the Plan. 
 7.9 Nature of Payments. All Awards made pursuant to the Plan are in consideration of services for the Company or 

  

 - 18 - 

 
a Subsidiary. Any gain realized pursuant to Awards under the Plan constitutes a special incentive payment to the Participant and will not be taken into
account as compensation for purposes of any other employee benefit plan of the Company or a Subsidiary, except as the Committee otherwise provides. The adoption of the Plan will have no effect on Awards made or to be made under any other benefit
plan covering an employee of the Company or a Subsidiary or any predecessor or successor of the Company or a Subsidiary. 
 7.10
Securities Law Compliance. Awards under the Plan are intended to satisfy the requirements of Rule 16b-3 under the Exchange Act. If any provision of this Plan or any grant of an Award would otherwise frustrate or conflict with this intent,
that provision will be interpreted and deemed amended so as to avoid conflict. No Participant will be entitled to a grant, exercise, transfer or payment of any Award if the grant, exercise, transfer or payment would violate the provisions of the
Sarbanes-Oxley Act of 2002 or any other applicable law. 
 7.11 Coordination with Other Plans. If this Plan provides a level of
benefits with respect to Awards that differs from the level of benefits provided under the Covidien Severance Plan for U.S. Officers and Executives, the Covidien Change in Control Severance Plan for Certain U.S. Officers and Executives or the
Covidien Severance Plan for U.S. Employees, then the terms of the plan that provides for the more favorable benefit to the Participant shall govern. 
 7.12 Section 409A Compliance. Notwithstanding any other provision of this Plan or an applicable Award Certificate to the contrary, the provisions of this Section 7.12 shall apply to all Awards that
were issued or became vested on or after January 1, 2005 and that are subject to Code Section 409A, but only with respect to the portion of such Award that is subject to Code Section 409A. 
 (a) General. To the extent the Committee (or Nominating Committee with respect to Director Awards) determines that any Award
granted under the Plan is subject to Code Section 409A, the Award Certificate evidencing such Award will incorporate the terms and conditions required by Code Section 409A. To the extent applicable, the Plan and the Award Certificate will
be interpreted in accordance with Code Section 409A and the applicable regulations and rulings thereunder. Notwithstanding any other provision of the Plan to the contrary, in the event that the Committee (or Nominating Committee with respect to
Director Awards) determines that any Award may be subject to Code Section 409A, the Committee may adopt such amendments to the Plan and/or the applicable Award Certificate or adopt policies and procedures or take any other action or actions,
including an action or amendment with retroactive effect, that the Committee (or Nominating Committee with respect to Director Awards) determines is necessary or appropriate to (i) exempt the Award from the application of Code Section 409A
or (ii) comply with the requirements of Code Section 409A. 
 (b) Modifications to Defined Terms. The
following modifications to Plan provisions (and, if necessary, applicable Award Certificate provisions) shall apply. 
 (i)
Any payment of deferred compensation that is to be made under an Award other than an Annual Performance Bonus upon the occurrence of a Change in Control or any change in the timing and/or form of such payment as a direct result of a Change in
Control (including payments made upon a specified date or event occurring after a Change in Control) shall not be made, or such change in timing and/or form shall not occur, unless such Change in Control is also a “change in ownership or
effective control” of the Company within the meaning of Code Section 409A(a)(2)(A)(v) and applicable regulations and rulings thereunder and such payment, or such change in timing and/or form, occurs no later than two (2) years after
the date of such change in ownership or effective control of the Company. Notwithstanding the foregoing, if the Committee takes an action pursuant to Section 5.4(b) to accelerate the payment of deferred compensation upon a Change in Control,
then any accelerated payment shall occur on a date specified in the applicable Award Certificate, which date shall be no later than ninety (90) days after a “change in ownership or effective control” of the Company. The payment of an
Annual Performance Bonus that is to be accelerated pursuant to Subsection 4.4(g) shall occur within thirty (30) days after a “change in ownership or effective control” of the Company within the meaning of Code
Section 409A(a)(2)(A)(v). 
 (ii) The definition of “Change in Control Termination” in subsection (b) of
that definition shall be deleted in its entirety and replaced with the following: 
 “(b) termination of the
Participant’s employment by the Participant after one of the following events: 
  

 - 19 - 

	 	(i)	the Company (1) assigns or causes to be assigned to the Participant duties inconsistent in any material respect with his or her position as in effect immediately prior to the
Change in Control; (2) makes or causes to be made any material adverse change in the Participant’s position (including titles and reporting relationships and level), authority, duties or responsibilities, or the budget over which the
Participant retains authority; or (3) takes or causes to be taken any other action which results in a material diminution in such position, authority, duties or responsibilities or the budget over which the Participant retains authority; or

  

	 	(ii)	the Company, without the Participant’s consent, (1) requires the Participant to relocate to a principal place of employment more than fifty (50) miles from his or her
existing place of employment; or (2) materially reduces the Participant’s base salary, annual bonus, or retirement, welfare, share incentive, perquisite (if any) and other benefits taken as a whole; 

 provided that an event described in (i) or (ii) above shall permit a Participant’s termination of employment to be deemed a Change in
Control Termination only if (x) the Participant provides written notice to the Company specifying in reasonable detail the event upon which the Participant is basing his termination within ninety (90) days after the occurrence of such
event, (y) the Company fails to cure such event within thirty (30) days after its receipt of such notice, and (z) the Participant terminates his employment within sixty (60) days after the expiration of such cure period.”

 (iii) The definition of ““Disabled” or “Disability”“ shall be deleted in its entirety and
replaced with the following: 
 ““Disabled” or “Disability” means that the Employee is receiving income replacement
benefits for a period of not less than three (3) months under a Company or Subsidiary accident and health plan covering the Employee by reason of any medically determinable physical or mental impairment that can be expected to result in death
or can be expected to last for a continuous period of not less than twelve (12) months.” 
 (iv) A Termination of
Directorship or Termination of Employment shall only occur where such Termination of Directorship or Termination of Employment is a “separation from service” within the meaning of Code Section 409A(a)(2)(A)(i) and the applicable
regulations and rulings thereunder. For purposes of determining whether a Termination of Directorship has occurred under this Subsection 7.12(b)(iii), services provided in the capacity of an employee or otherwise shall be excluded. 
 (c) Modifications to or Adjustments of Awards. Any modifications to an Award pursuant to Subsection 3.2(g) or adjustments of an
Award pursuant to Subsections 4.8 or 5.3 shall comply with the requirements of Section 409A. 
 (d) Specified
Employees. Payments to any Participant who is a “specified employee” of deferred compensation that is subject to Code Section 409A(a)(2) and that becomes payable upon, or that is accelerated upon, such Participant’s
Termination of Employment (as modified by Subsection 7.12(b)(iii)), shall not be made on or before the date which is six (6) months following such Participant’s Termination of Employment (or, if earlier, such Participant’s death). A
specified employee for this purpose shall be determined by the Committee or its delegate in accordance with the provisions of Code Section 409A and the regulations and rulings thereunder. 
 7.13 Section 457A Compliance. To the extent the Committee (or Nominating Committee with respect to Director Awards) determines that any Award
granted under the Plan is subject to Code Section 457A, the Award Certificate evidencing such Award will incorporate the terms and conditions required by Code Section 457A. To the extent applicable, the Plan and the Award Certificate will
be interpreted in accordance with Code Section 457A and applicable guidance issued thereunder. Notwithstanding any other provision of the Plan to the contrary, in the event that the Committee (or Nominating Committee with respect to Director
Awards) determines that any Award may be subject to Code Section 457A, the Committee may adopt such amendments to the Plan and/or the applicable Award Certificate or adopt policies and procedures or take any other action or actions, including
an action or amendment with retroactive effect, that the Committee (or Nominating Committee with respect to Director Awards) determines is necessary or appropriate to (i) exempt the 

  

 - 20 - 

 
Award from the application of Code Section 457A or (ii) comply with the requirements of Code Section 457A. 
 7.14 Governing Law, Severability. The Plan and all determinations made and actions taken under the Plan will be governed by the law of Ireland and
construed accordingly. If any provision of the Plan is held unlawful or otherwise invalid or unenforceable in whole or in part, the unlawfulness, invalidity or unenforceability will not affect any other parts of the Plan, which parts will remain in
full force and effect. 
  

 - 21 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]